metricas
covid
Buscar en
Medicina Clínica (English Edition)
Toda la web
Inicio Medicina Clínica (English Edition) Anaemia of chronic diseases: Pathophysiology, diagnosis and treatment
Journal Information

Statistics

Follow this link to access the full text of the article

Review
Anaemia of chronic diseases: Pathophysiology, diagnosis and treatment
Anemia de las enfermedades crónicas: fisiopatología, diagnóstico y tratamiento
Ricardo de las Cuevas Allendea,, Lucía Díaz de Entresotosb, Susana Conde Díezc,
,
a Servicio Cántabro de Salud, Centro de Salud El Alisal, Santander, Cantabria, Spain
b Servicio Cántabro de Salud, Santander, Cantabria, Spain
c Servicio Cántabro de Salud, Centro de Salud Altamira, Cantabria, Spain
Read
8
Times
was read the article
4
Total PDF
4
Total HTML
Share statistics
 array:24 [
  "pii" => "S2387020621000528"
  "issn" => "23870206"
  "doi" => "10.1016/j.medcle.2020.07.022"
  "estado" => "S300"
  "fechaPublicacion" => "2021-03-12"
  "aid" => "5421"
  "copyright" => "Elsevier España, S.L.U.. All rights reserved"
  "copyrightAnyo" => "2020"
  "documento" => "article"
  "crossmark" => 1
  "subdocumento" => "rev"
  "cita" => "Med Clin. 2021;156:235-42"
  "abierto" => array:3 [
    "ES" => false
    "ES2" => false
    "LATM" => false
  ]
  "gratuito" => false
  "lecturas" => array:1 [
    "total" => 0
  ]
  "Traduccion" => array:1 [
    "es" => array:19 [
      "pii" => "S0025775320306539"
      "issn" => "00257753"
      "doi" => "10.1016/j.medcli.2020.07.035"
      "estado" => "S300"
      "fechaPublicacion" => "2021-03-12"
      "aid" => "5421"
      "copyright" => "Elsevier España, S.L.U."
      "documento" => "article"
      "crossmark" => 1
      "subdocumento" => "rev"
      "cita" => "Med Clin. 2021;156:235-42"
      "abierto" => array:3 [
        "ES" => false
        "ES2" => false
        "LATM" => false
      ]
      "gratuito" => false
      "lecturas" => array:1 [
        "total" => 0
      ]
      "es" => array:13 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Revisi&#243;n</span>"
        "titulo" => "Anemia de las enfermedades cr&#243;nicas&#58; fisiopatolog&#237;a&#44; diagn&#243;stico y tratamiento"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "tieneResumen" => array:2 [
          0 => "es"
          1 => "en"
        ]
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "235"
            "paginaFinal" => "242"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Anaemia of chronic diseases&#58; Pathophysiology&#44; diagnosis and treatment"
          ]
        ]
        "contieneResumen" => array:2 [
          "es" => true
          "en" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:7 [
            "identificador" => "fig0005"
            "etiqueta" => "Figura 1"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "gr1.jpeg"
                "Alto" => 2061
                "Ancho" => 2167
                "Tamanyo" => 391989
              ]
            ]
            "descripcion" => array:1 [
              "es" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">S&#237;ntesis de hepcidina&#46; La IL-6 activa la v&#237;a de se&#241;alizaci&#243;n JAK-STAT3 <span class="elsevierStyleItalic">&#40;janus kinasa-signal transducer and activator of transcription&#41;&#59;</span> la IL1 y la activina B &#40;Act-B&#41; aumentan la transcripci&#243;n de HAMP a trav&#233;s de la se&#241;alizaci&#243;n BMP&#47;SMAD&#46; El hierro plasm&#225;tico&#44; unido a la transferrina &#40;Tf-Fe2&#41; &#40;holotransferrina&#41;&#44; es un sensor de los hepatocitos para regular la transcripci&#243;n de hepcidina porque activa la ruta BMP-HJV-SMAD <span class="elsevierStyleItalic">&#40;bone morphogenetic protein-hemojuvelina-small mothers against decapentaplegic</span>&#41;&#46; En las situaciones de hiposideremia&#44; la holotransferrina se une al receptor de la transferrina1 &#40;TfR1&#41;&#44; no se activa la v&#237;a BMP-SMAD y no se sintetiza hepcidina&#44; lo que facilita la llegada de hierro al plasma&#46; Cuando la hiposideremia se ha subsanado&#44; la holotransferrina se desplaza hacia el receptor TfR2 y forma un complejo con HFE &#40;prote&#237;na de la hemocromatosis humana&#41;&#44; que activa la v&#237;a BMP en presencia de sus receptores &#40;BMPR1 y BMPR2&#41;&#44; HJV y neoginina &#40;NEO&#41;&#44; promoviendo la s&#237;ntesis de hepcidina&#46; La eritroferrona &#40;ERFE&#41;&#44; GDF15 &#40;<span class="elsevierStyleItalic">growth differentiation factor&#41;</span> y TWSG1 &#40;<span class="elsevierStyleItalic">twisted gastrulation BMP signaling modulator</span>&#41; inhiben la s&#237;ntesis de hepcidina porque bloquean la v&#237;a SMAD&#46; Otro inhibidor de la hepcidina es la matriptasa-2 &#40;MT-2&#41;&#44; que bloquea la HJV impidiendo la activaci&#243;n del complejo BMP&#46; La hipoxia tisular y la eritropoyetina tambi&#233;n inhiben la s&#237;ntesis de hepcidina&#46;</p>"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Ricardo de las Cuevas Allende, Luc&#237;a D&#237;az de Entresotos, Susana Conde D&#237;ez"
            "autores" => array:3 [
              0 => array:2 [
                "nombre" => "Ricardo"
                "apellidos" => "de las Cuevas Allende"
              ]
              1 => array:2 [
                "nombre" => "Luc&#237;a"
                "apellidos" => "D&#237;az de Entresotos"
              ]
              2 => array:2 [
                "nombre" => "Susana"
                "apellidos" => "Conde D&#237;ez"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S2387020621000528"
          "doi" => "10.1016/j.medcle.2020.07.022"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => false
            "ES2" => false
            "LATM" => false
          ]
          "gratuito" => false
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020621000528?idApp=UINPBA00004N"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775320306539?idApp=UINPBA00004N"
      "url" => "/00257753/0000015600000005/v1_202102240836/S0025775320306539/v1_202102240836/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S2387020621000498"
    "issn" => "23870206"
    "doi" => "10.1016/j.medcle.2020.04.030"
    "estado" => "S300"
    "fechaPublicacion" => "2021-03-12"
    "aid" => "5203"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46;"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "sco"
    "cita" => "Med Clin. 2021;156:243-7"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Special article</span>"
      "titulo" => "Euthanasia&#58; Approve without knowing"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "243"
          "paginaFinal" => "247"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Eutanasia&#58; aprobar sin conocer"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:8 [
          "identificador" => "fig0015"
          "etiqueta" => "Fig&#46; 3"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr3.jpeg"
              "Alto" => 886
              "Ancho" => 1532
              "Tamanyo" => 55226
            ]
          ]
          "detalles" => array:1 [
            0 => array:3 [
              "identificador" => "at0015"
              "detalle" => "Fig&#46; "
              "rol" => "short"
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Results from the nursing professionals of the Intensive Care &#40;ICU&#41;&#44; Emergency and Oncology departments&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Bernat Gonzalez Pineda, Carolina Rossana Villar&#243; Pellejero, Jos&#233; Felipe Solsona Duran"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "Bernat"
              "apellidos" => "Gonzalez Pineda"
            ]
            1 => array:2 [
              "nombre" => "Carolina Rossana"
              "apellidos" => "Villar&#243; Pellejero"
            ]
            2 => array:2 [
              "nombre" => "Jos&#233; Felipe"
              "apellidos" => "Solsona Duran"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S002577532030289X"
        "doi" => "10.1016/j.medcli.2020.04.022"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => false
          "ES2" => false
          "LATM" => false
        ]
        "gratuito" => false
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S002577532030289X?idApp=UINPBA00004N"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020621000498?idApp=UINPBA00004N"
    "url" => "/23870206/0000015600000005/v1_202103120836/S2387020621000498/v1_202103120836/en/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S238702062100053X"
    "issn" => "23870206"
    "doi" => "10.1016/j.medcle.2020.10.013"
    "estado" => "S300"
    "fechaPublicacion" => "2021-03-12"
    "aid" => "5486"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46;"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "sco"
    "cita" => "Med Clin. 2021;156:233-4"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>"
      "titulo" => "Clinical implications of advanced interatrial block&#58; Bay&#233;s syndrome"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "233"
          "paginaFinal" => "234"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Implicaciones cl&#237;nicas del bloqueo interauricular avanzado&#58; s&#237;ndrome de Bay&#233;s"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Antoni Bay&#233;s-de-Luna, Antoni Bay&#233;s-Gen&#237;s"
          "autores" => array:2 [
            0 => array:2 [
              "nombre" => "Antoni"
              "apellidos" => "Bay&#233;s-de-Luna"
            ]
            1 => array:2 [
              "nombre" => "Antoni"
              "apellidos" => "Bay&#233;s-Gen&#237;s"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0025775320307685"
        "doi" => "10.1016/j.medcli.2020.10.013"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => false
          "ES2" => false
          "LATM" => false
        ]
        "gratuito" => false
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775320307685?idApp=UINPBA00004N"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S238702062100053X?idApp=UINPBA00004N"
    "url" => "/23870206/0000015600000005/v1_202103120836/S238702062100053X/v1_202103120836/en/main.assets"
  ]
  "en" => array:20 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Review</span>"
    "titulo" => "Anaemia of chronic diseases&#58; Pathophysiology&#44; diagnosis and treatment"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "235"
        "paginaFinal" => "242"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Ricardo de las Cuevas Allende, Luc&#237;a D&#237;az de Entresotos, Susana Conde D&#237;ez"
        "autores" => array:3 [
          0 => array:3 [
            "nombre" => "Ricardo"
            "apellidos" => "de las Cuevas Allende"
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#9674;</span>"
                "identificador" => "fn0005"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "Luc&#237;a"
            "apellidos" => "D&#237;az de Entresotos"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          2 => array:4 [
            "nombre" => "Susana"
            "apellidos" => "Conde D&#237;ez"
            "email" => array:1 [
              0 => "sue_santander@yahoo.es"
            ]
            "referencia" => array:3 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
              1 => array:2 [
                "etiqueta" => "&#42;"
                "identificador" => "cor0005"
              ]
              2 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#9674;</span>"
                "identificador" => "fn0005"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:3 [
          0 => array:3 [
            "entidad" => "Servicio C&#225;ntabro de Salud&#44; Centro de Salud El Alisal&#44; Santander&#44; Cantabria&#44; Spain"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Servicio C&#225;ntabro de Salud&#44; Santander&#44; Cantabria&#44; Spain"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
          2 => array:3 [
            "entidad" => "Servicio C&#225;ntabro de Salud&#44; Centro de Salud Altamira&#44; Cantabria&#44; Spain"
            "etiqueta" => "c"
            "identificador" => "aff0015"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Anemia de las enfermedades cr&#243;nicas&#58; fisiopatolog&#237;a&#44; diagn&#243;stico y tratamiento"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:8 [
        "identificador" => "fig0005"
        "etiqueta" => "Fig&#46; 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 2086
            "Ancho" => 2216
            "Tamanyo" => 316839
          ]
        ]
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at0005"
            "detalle" => "Fig&#46; "
            "rol" => "short"
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Synthesis of hepcidin&#46; IL-6 activates the JAK-STAT3 <span class="elsevierStyleItalic">&#40;janus kinase-signal transducer and activator of transcription&#41;</span> signalling pathway&#59; IL1 and activin B &#40;Act-B&#41; increase HAMP transcription through BMP&#47;SMAD signalling&#46; Plasma iron&#44; bound to transferrin &#40;Tf-Fe2&#41; &#40;holo-transferrin&#41;&#44; is a sensor of hepatocytes to regulate hepcidin transcription because it activates the BMP-HJV-SMAD <span class="elsevierStyleItalic">&#40;bone morphogenetic protein-hemojuvelin-small mothers against decapentaplegic</span>&#41; pathway&#46; In hyposideraemia&#44; holo-transferrin binds to the transferrin receptor-1 &#40;TfR1&#41;&#44; the BMP-SMAD pathway is not activated&#44; and the hepcidin is not synthesised&#44; which aids the entry of iron into the plasma&#46; When the hyposideraemia has been resolved&#44; the holo-transferrin binds to the TfR2 receptor and forms a complex with HFE &#40;hereditary hemochromatosis protein&#41;&#44; which activates the BMP pathway in the presence of its receptors &#40;BMPR1 and BMPR2&#41;&#44; of HJV and neogenin &#40;NEO&#41;&#44; promoting the hepcidin synthesis&#46; Erythroferrone &#40;Erfe&#41;&#44; GDF15 &#40;<span class="elsevierStyleItalic">growth differentiation factor&#41;</span> and TWSG1 &#40;<span class="elsevierStyleItalic">twisted gastrulation BMP signalling modulator</span>&#41; inhibit hepcidin synthesis by blocking the SMAD pathway&#46; Another inhibitor of hepcidin is matriptase-2 &#40;MT-2&#41;&#44; which blocks HJV by preventing the activation of the BMP complex&#46; Tissue hypoxia and erythropoietin also inhibit hepcidin synthesis&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Anaemia of chronic disease &#40;ACD&#41; or anaemia of inflammation occurs in the context of an inflammatory process&#44; in which there is an activation of the immune system with the release of cytokines and elevation of hepcidin&#44; that decreases plasma iron with suppression of erythropoiesis&#46;<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> The anaemia is mild&#47;moderate &#40;hemoglobin between 8 and 12&#8239;g&#47;dL&#41; and is usually normocytic&#44; normochromic&#44; and hypoproliferative&#46;<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> It is the second most prevalent anaemia after iron deficiency anaemia&#44; and it is the most common in the elderly&#46; Up to a third of elderly people who present anaemia have ACD&#46;<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> Also&#44; it is the most frequent anaemia among hospitalised patients or those with chronic diseases&#46; It is estimated that up to 40&#37; of anaemias worldwide are ACD&#44; or combinations with other types of anaemia but where the contribution of ACD is very important&#46;<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">All the processes that include chronic inflammatory phenomena are potentially generators of an ACD&#44; such as rheumatoid arthritis&#44; systemic lupus erythematosus&#44; vasculitis&#44; sarcoidosis&#44; inflammatory bowel disease&#44; neoplastic diseases&#44; chronic kidney disease &#40;CKD&#41;&#44; acute&#47;chronic bacterial infections&#44; fungal&#44; viral and parasitic diseases&#44; as well as chronic rejection of organ transplants&#44; respiratory failure&#44; heart failure&#44; obesity and other chronic processes&#46;<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> Elevated hepcidin levels in infections represent a host defense mechanism against infections because it limits the availability of iron to the microorganisms&#46;<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1&#44;3</span></a></p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Regulation of iron metabolism</span><p id="par0015" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Hepcidin</span>&#44; the main regulator of iron metabolism&#44; is synthesised in the liver and its function is to control the entry of iron into the plasma&#46; Iron is supplied with food in the ferric form and&#44; after being reduced to the ferrous form&#44; it is absorbed by the duodenal enterocytes and subsequently released into the plasma&#46;<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> The <span class="elsevierStyleItalic">ferroportin</span> is responsible for the release of iron from the enterocytes&#44; macrophages and hepatocytes into the plasma&#46;<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> Hepcidin binds to ferroportin and blocks its function&#44; preventing the release of iron into the plasma&#46; This causes hyposideraemia and the accumulation of iron&#44; in the form of ferritin&#44; in enterocytes&#44; macrophages and hepatocytes&#46;<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3&#44;4</span></a> Hepcidin plays a fundamental role in all iron disorders&#44; both in excess and in deficit&#46; An excess of hepcidin contributes to the development of anaemia due to iron deficiency or its restricted use in the ACD&#44; while its deficiency causes iron overload&#46;<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> In chronic inflammatory diseases high hepcidin levels produce functional iron deficiency anaemia&#44; because there is no reserve excess iron available for erythropoiesis&#46;<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3&#44;5</span></a> Hepcidin is an acute phase reactant that responds to a wide variety of inflammatory mediators and signals&#44; which stimulate its transcription through different signalling pathways&#46;<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a></p><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Regulation of the hepcidin expression</span><p id="par0020" class="elsevierStylePara elsevierViewall">Hepcidin transcription&#44; encoded by the HAMP gene <span class="elsevierStyleItalic">&#40;hepcidin antimicrobial peptide</span>&#41;&#44; is carried out by different activating and inhibiting signals acting in a synchronised manner<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3&#44;4</span></a> &#40;<a class="elsevierStyleCrossRef" href="#fig0005">Fig&#46; 1</a>&#41;&#46; The former include the inflammatory processes and the plasma iron level&#46;<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> In inflammatory diseases&#44; the increase in hepcidin is mediated by cytokines produced by the activation of the immune system&#44; especially IL-6 and IL-22&#44; which activate the JAK-STAT3 <span class="elsevierStyleItalic">&#40;janus kinase-signal transducer and activator of transcription&#41;</span> signalling pathway&#46;<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3&#44;4</span></a> IL1 and activin B &#40;Act-B&#41; also intervene&#44; by increasing the HAMP transcription via BMP&#47;SMAD &#40;<span class="elsevierStyleItalic">bone morphogenetic protein-small mothers against decapentaplegic</span>&#41; signaling&#46;<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> Both pathways are closely connected&#44;<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a> so much so that efficient induction of hepcidin by the inflammatory pathway requires a threshold of BMP6&#47;SMAD signaling&#46;<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a></p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0025" class="elsevierStylePara elsevierViewall">Hepcidin regulation by plasma iron is carried out through the BMP&#47;SMAD pathway&#46; The mechanism involves the secretion of BMP6 by the liver&#8217;s sinusoidal endothelial cells&#44; which bind to the BMP type I &#40;ALK2&#44; ALK3&#44; ALK6&#41; and type II &#40;ActRIIA&#44; BMPRII&#41; receptors in the hepatocytes&#44; in order to activate the SMAD cascade signaling&#46;<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3&#44;4</span></a> Iron-bound transferrin &#40;Tf-Fe2&#41; &#40;holo-transferrin&#41; is a hepatocyte sensor for the control of the hepcidin transcription&#46; In hyposideraemia&#44; the Tf-Fe2 complex binds to the transferrin receptor-1 &#40;TfR1&#41;&#44; the BMP-SMAD pathway is not activated&#44; and the hepcidin is not synthesised&#44; which aids the entry of iron into the plasma&#46; When the hyposideraemia has been resolved&#44; the holo-transferrin binds to the TfR2 receptor and forms a complex with HFE &#40;hereditary hemochromatosis protein&#41;&#44;<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a> which activates the BMP pathway in the presence of its receptors &#40;BMPR1 and BMPR2&#41;&#44; of HJV &#40;hemojuvelin&#41; and neogenin&#44; promoting the SMAD1&#47;5&#47;8 phosphorylation&#44; the transcription of HAMP and the hepcidin synthesis<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3&#44;4&#44;8</span></a> &#40;<a class="elsevierStyleCrossRef" href="#fig0005">Fig&#46; 1</a>&#41;&#46;</p><p id="par0030" class="elsevierStylePara elsevierViewall">The inhibitory signals of hepcidin come from the erythropoiesis and are related to different proteins&#44; produced in the erythroblasts&#44; which block its production when iron is needed for the synthesis of haemoglobin&#46;<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3&#44;4</span></a> The most important protein is erythroferrone &#40;Erfe&#41;&#44; but there are others such as <span class="elsevierStyleItalic">growth differentiation factor 15</span> &#40;GDF15&#41; and <span class="elsevierStyleItalic">twisted gastrulation BMP</span> signaling <span class="elsevierStyleItalic">modulator</span> &#40;TWSG1&#41; which inhibit the SMAD pathway<a class="elsevierStyleCrossRefs" href="#bib0045"><span class="elsevierStyleSup">9&#44;10</span></a> &#40;<a class="elsevierStyleCrossRef" href="#fig0005">Fig&#46; 1</a>&#41;&#46; Matriptase-2 &#40;MT-2&#41;&#44; encoded by the <span class="elsevierStyleItalic">TMPRSS6</span> gene&#44; is another hepcidin inhibitor because it blocks the HJV and prevents the activation of the BMP complex&#46;<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">11</span></a> Other inhibitory signs of hepcidin synthesis are tissue hypoxia and erythropoietin &#40;EPO&#41;&#44; which generate erythroblastic hyperplasia with the consequent increase in Erfe&#44; GDF15 and TWSG1 levels&#46;<a class="elsevierStyleCrossRefs" href="#bib0050"><span class="elsevierStyleSup">10&#44;12</span></a></p></span></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Pathophysiology</span><p id="par0035" class="elsevierStylePara elsevierViewall">The cause of anaemia in chronic diseases is multifactorial and the origin is in the activation of the immune system by autoantigens&#44; microbial molecules or tumour antigens&#44; which gives rise to the release of multiple inflammatory cytokines and free radicals that favour the increase of the hepcidin&#46;<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1&#44;3</span></a> The cytokines involved are IL-6&#44; IL-1b&#44; IL-22&#44; lipopolysaccharides &#40;LPS&#41;&#44; tumor necrosis factor alpha &#40;TNF&#9001;&#41;&#44; interferon gamma &#40;INF&#947;&#41; and other&#46;<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1&#44;13</span></a> The consequences of these disorders are changes in iron homeostasis&#44; especially hyposideraemia&#44; erythropoiesis suppression&#44; shortened erythroid survival&#44; and decreased EPO production<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1&#44;4</span></a> &#40;<a class="elsevierStyleCrossRef" href="#fig0010">Fig&#46; 2</a>&#41;&#46;</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Alteration of iron homeostasis</span><p id="par0040" class="elsevierStylePara elsevierViewall">Hepcidin increase causes ferroportin degradation resulting&#44; on the one hand&#44; in hyposideraemia due to a decrease in iron transferred to plasma&#44; and on the other&#44; in the accumulation of iron in the form of ferritin in enterocytes&#44; macrophages and hepatocytes<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3&#44;4</span></a> &#40;<a class="elsevierStyleCrossRef" href="#fig0015">Fig&#46; 3</a>&#41;&#46; Hyposideraemia is one of the most important factors in ACD&#44; as functional iron deficiency anaemia occurs because iron&#44; although it is abundant in the storage organs&#44; is not available for effective erythropoiesis&#46;<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3&#44;4</span></a></p><elsevierMultimedia ident="fig0015"></elsevierMultimedia></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Erythropoiesis suppression</span><p id="par0045" class="elsevierStylePara elsevierViewall">The second pathogenic factor in ACD is erythropoiesis suppression&#44; directly related to EPO&#46; In most patients with ACD&#44; the EPO levels are lower than expected for the degree of anaemia they usually present&#46; This may be the result of two causes&#59; on the one hand&#44; hyposideraemia gives rise to an iron deficiency in the erythroblasts&#44; which reduces the EPO receptor gene &#40;EPOR&#41; expression via a blunted expression of an EpoR control regulator known as <span class="elsevierStyleItalic">scribble</span> &#40;SCB&#41;<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3&#44;14</span></a> and&#44; also&#44; due to the inhibitory effect of the cytokines &#40;<a class="elsevierStyleCrossRef" href="#fig0015">Fig&#46; 3</a>&#41;&#46; On the other hand&#44; lower levels of EPO may be related to an inhibitory effect of IL-1 and TNF-&#945; at the renal level&#44; by the mediated GATA-2 transcription gene&#44; since EPO-mediated signalling is reduced and is inversely linked to the circulating levels of cytokines<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3&#44;13</span></a> &#40;<a class="elsevierStyleCrossRef" href="#fig0015">Fig&#46; 3</a>&#41;&#46; Hypoxia and the reduced availability of EPO in ACD negatively impact the hepcidin blockers&#44; such as Erfe&#44; GDF15 and TWSG1&#44; which under physiological conditions slow down the hepcidin synthesis because they inhibit the SMAD pathway<a class="elsevierStyleCrossRefs" href="#bib0045"><span class="elsevierStyleSup">9&#44;13&#44;15</span></a> &#40;<a class="elsevierStyleCrossRefs" href="#fig0005">Figs&#46; 1 and 3</a>&#41;&#46;</p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Erythrophagocytosis and a shortened erythrocyte half-life</span><p id="par0050" class="elsevierStylePara elsevierViewall">Reduction in the erythrocyte half-life due to erythrophagocytosis is another common pathogenic factor in the inflammatory setting&#46;<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> This phenomenon is produced by activation of macrophages by cytokines<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> &#40;<a class="elsevierStyleCrossRef" href="#fig0015">Fig&#46; 3</a>&#41;&#46; Shortened red blood cell survival is a minor pathogenic factor in ACD&#44; but it plays a greater role in severe infections and in critical situations accompanied by a massive release of cytokines that promote erythrophagocytosis and hemolysis&#46;<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> In these situations&#44; anaemia occurs in the first days of the event&#44; before there is a decrease in erythropoiesis&#44; so that anaemia is explained by the shortened erythrocyte half-life and by hemodilution&#44; which is common in these clinical situations&#46;<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a></p></span></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Diagnosis</span><p id="par0055" class="elsevierStylePara elsevierViewall">In addition to the specific symptoms of the underlying disease and the associated systemic inflammatory process&#44; patients&#44; who are elderly&#44; in general&#44; present an increase in acute phase reactants&#44; such as a sedimentation rate&#44; C-reactive protein and others&#46; These&#44; together with anaemia&#44; give rise to a whole procession of clinical data&#44; more or less intense&#44; depending on the hemoglobin levels&#46; Some critical patients with acute inflammatory processes may present a clinical symptoms similar to that of &#171;cytokine release syndrome&#187;&#44; with massive rise in cytokines&#44; especially IL-6&#46; Symptoms of anaemia are the consequence of hypoxia&#44; but effective iron deficiency displays additional symptoms because it also impairs mitochondrial function&#44; cellular metabolism&#44; enzyme activities&#44; and neurotransmitter synthesis&#46;<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1&#44;16</span></a> Patients with ACD have a &#171;functional iron deficiency&#187; and the anaemia they present is characteristically mild to moderate normocytic&#47;normochromic&#46;<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a></p><p id="par0060" class="elsevierStylePara elsevierViewall">The diagnosis of inflammatory anaemia is mainly one of exclusion&#46; It is best diagnosed by documenting an anaemia of low production in the context of an inflammatory disease&#46; Patients with ACD often present hyposideraemia&#44; low transferrin saturation&#44; reticulocytopenia&#44; and important findings are increased hepcidin and serum ferritin levels&#44; which translate into elevated iron stores in the MPS macrophages&#46;<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3&#44;16</span></a> The differential diagnosis should be made with the true iron deficiency anaemia&#44; in which there is an absolute deficit of iron&#44; with lab results that show microcytic and hypochromic anaemia with hyposidaeremia&#44; increased transferrin&#44; and reticulocytopenia&#44; but with low levels of ferritin and hepcidin&#44; which would rule out ACD&#46;<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> In addition&#44; the soluble transferrin receptor is elevated in iron deficiency anaemia and normal in ACD&#46; Sometimes&#44; the ACD can coexist with a true iron deficiency&#44; in which case the location of blood loss should be investigated&#46; However&#44; in these cases the ferritin is not usually elevated&#44; it can be normal or a little low<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">16</span></a> &#40;<a class="elsevierStyleCrossRef" href="#fig0020">Fig&#46; 4</a>&#41;&#46; An evaluation of &#171;inadequately low&#187; ferritin&#44; in the context of an iron-deficient ACD&#44; can be difficult to define in clinical practice&#44; but considering this aspect is important because&#44; in these cases&#44; intravenous iron treatment can be effective&#46;</p><elsevierMultimedia ident="fig0020"></elsevierMultimedia></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Treatment</span><p id="par0065" class="elsevierStylePara elsevierViewall">The ACD treatment objective should be to cure the underlying disease&#44; and if this is not possible&#44; to achieve the best possible control of the symptoms&#46; Anaemia is usually a consequence of the disease and it often contributes to greater clinical manifestations depending on its severity&#44; so correcting the anaemia would improve the patient&#8217;s quality of life&#46;<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> In general&#44; the anaemia is moderate which means that blood transfusions are unnecessary&#46; However&#44; if the anaemia is severe&#44; they will need to be used as an emergency treatment&#46;<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> Intravenous iron treatment may be justified as a temporary measure&#44; in some cases of ACD&#44; but in the long run it can be harmful as it causes the patient to have an excess of iron&#46;<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> EPO may be beneficial in some patients&#44; as an alternative to chronic red blood cell transfusion&#44; but it is not approved for ACD and its use is based on the fact that it sometimes improves anaemia&#44; and the similarity that exists between ACD and CKD anaemia&#44; as it is approved for the latter&#46;<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3&#44;17</span></a></p><p id="par0070" class="elsevierStylePara elsevierViewall">As hyposideraemia is the cause of anaemia&#44; the therapeutic goal should be to increase plasma iron levels&#46;<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> New treatment strategies for its increase focus on reversing the overexpression of hepcidin&#44; in order to favour the mobilisation of iron sequestered in MPS cells&#46;<a class="elsevierStyleCrossRefs" href="#bib0090"><span class="elsevierStyleSup">18&#8211;20</span></a> The strategies being investigated are aimed at enhancing erythropoiesis and increasing endogenous erythropoietin levels on the one hand&#44; and at preventing the action of hepcidin&#44; either by blocking its synthesis&#44; neutralizing circulating hepcidin or preventing the action of hepcidin on ferroportin on the other<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1&#44;3&#44;18&#8211;20</span></a> &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#41;&#46; Much research is being conducted involving the various agents that could modify the hepcidin-ferroportin axis or the various regulators involved&#46;<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">20</span></a> Most of these agents are effective in animal models and several are undergoing human testing&#46; In ACD&#44; the target is IL6 because its neutralisation reduces the hepcidin levels and corrects the anaemia&#44; as has been shown in the treatment of inflammatory diseases and in Castleman&#8217;s disease&#44;<a class="elsevierStyleCrossRefs" href="#bib0105"><span class="elsevierStyleSup">21&#44;22</span></a> but these agents must be well tolerated as well as being effective&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Erythropoiesis potentiation</span><p id="par0075" class="elsevierStylePara elsevierViewall">The increase in erythropoiesis leads to erythropoiesis hyperplasia and an elevation of erythropherrone that blocks the SMAD pathway and slows down the synthesis of hepcidin&#46; Therefore&#44; any agent that improves erythropoiesis could be effective in the control of ACD&#46; High doses of EPO may be able to overcome the resistance to EPO observed in these diseases&#44; by partial suppression of hepcidin&#46;<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3&#44;17</span></a> It is known that the kidneys of CKD patients retain the ability to produce erythropoietin and that in hypoxic situations the prolyl hydroxylase enzyme activity decreases&#44; physiologically leading to an increase in the transcriptional activity of the hypoxia inducible factor &#40;HIF&#41;&#44; which induces the endogenous EPO expression&#44; corrects functional iron deficiency&#44; and activates erythropoiesis&#46;<a class="elsevierStyleCrossRefs" href="#bib0115"><span class="elsevierStyleSup">23&#44;24</span></a> Pharmacological prolyl hydroxylase inhibitors &#40;PHI&#41; mimic the natural hypoxic response&#44; thereby increasing HIF&#46; There are several PHI agents that&#44; by increasing endogenous EPO&#44; improve erythropoiesis and reduce hepcidin levels in patients with anaemia and chronic inflammatory processes&#46; Effective agents already in phase II&#47;III trials are&#58; vadadustat &#40;AKB-6548&#41;&#44; molidustat &#40;BAY85-3934&#41;&#44; daprodustat &#40;GSK1278863&#41; and roxadustat &#40;FG-4592&#41;&#46;<a class="elsevierStyleCrossRefs" href="#bib0120"><span class="elsevierStyleSup">24&#44;25</span></a> In two phase III studies in patients with CKD and anaemia&#44; an oral PHI &#40;roxadustat&#41; was compared with erythropoietin-&#945;&#59; in one of the studies&#44; the patients were not on hemodialysis and in the other they were already on dialysis&#46;<a class="elsevierStyleCrossRefs" href="#bib0130"><span class="elsevierStyleSup">26&#44;27</span></a> The results were that the increase in hemoglobin in the roxadustat group was greater than that of the placebo in those not on dialysis<a class="elsevierStyleCrossRef" href="#bib0130"><span class="elsevierStyleSup">26</span></a> and it was not inferior to erythropoietin-&#945; in hemodialysis patients&#46;<a class="elsevierStyleCrossRef" href="#bib0135"><span class="elsevierStyleSup">27</span></a> Therefore&#44; stabilisation of HIF through inhibition of the prolyl-hydroxylase enzymes family is a novel approach and may be an effective therapeutic target in the treatment of CKD anaemia&#44; since the increase in EPO is physiological thereby avoiding higher doses of conventional EPO and the resulting cardiovascular side effects&#46;<a class="elsevierStyleCrossRef" href="#bib0120"><span class="elsevierStyleSup">24</span></a> However&#44; prolyl hydroxylase inhibitors correct the CKD anaemia through multiple biological pathways&#44; such as increasing erythropoietin levels&#44; stimulating erythropoiesis&#44; decreasing erythropherrone-mediated hepcidin levels&#44; and the correcting hyposideraemia&#44; and due to their angiogenic action they are not exempt from side effects&#46; So monitoring the consequences of their long-term use will be essential&#46;<a class="elsevierStyleCrossRefs" href="#bib0120"><span class="elsevierStyleSup">24&#44;28</span></a></p></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Hepcidin antagonists</span><p id="par0080" class="elsevierStylePara elsevierViewall">Hepcidin is the main cause of anaemia in chronic diseases because it generates hyposideraemia and retains iron in the MPS cells&#44; so its pharmacological inhibition would facilitate iron mobilisation&#44; favouring erythropoiesis and the correction of anaemia&#46;<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1&#44;3</span></a> The hepcidin antagonists under study are aimed at blocking its synthesis&#44; at neutralising circulating hepcidin and&#44; also&#44; at preventing the action of hepcidin on the ferroportin&#46;<a class="elsevierStyleCrossRefs" href="#bib0090"><span class="elsevierStyleSup">18&#8211;20</span></a> The interest in these studies is very great&#44; as evidenced by the fact that in October 2019&#44; in ClinicalTrials&#46;gov&#44; there were 221 registered clinical trials on hepcidin&#44; 67 of which were investigating hepcidin in chronic diseases or cancer&#46;</p></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Inhibition of hepcidin production</span><p id="par0085" class="elsevierStylePara elsevierViewall">There are two main pathways that control hepcidin synthesis&#46; One is related to the plasma iron level&#44; through the BMP6-HJV-SMAD pathway&#44; and the other is related to inflammatory processes through the IL6-JAK-STAT3 pathway&#46; The latter has more prominence in the ACD<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#41;&#46; The in vitro studies have revealed the existence of a cross connection between the two pathways&#44; since treatments that block the BMP pathway also inhibit the expression of hepcidin through the IL-6-STAT3 inflammatory signalling pathway and&#44; also&#44; efficient induction of hepcidin by the inflammatory pathway requires a threshold of BMP6&#47;SMAD signaling&#46;<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a></p></span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Suppression of the inflammatory pathway</span><p id="par0090" class="elsevierStylePara elsevierViewall">Hepcidin is activated by IL-6 through the IL-6 receptor &#40;IL-6R&#41; and JAK2-STAT3 signalling&#46; So&#44; blocking IL6 with siltuximab&#44;<a class="elsevierStyleCrossRef" href="#bib0110"><span class="elsevierStyleSup">22</span></a> the IL6 receptor with tocilizumab<a class="elsevierStyleCrossRef" href="#bib0145"><span class="elsevierStyleSup">29</span></a> and JAK1&#47;2 with momelotinib<a class="elsevierStyleCrossRefs" href="#bib0150"><span class="elsevierStyleSup">30&#44;31</span></a> prevent STAT3 phosphorylation&#44; decrease hepcidin levels&#44; normalise sideremia and improve anaemia in monkeys with arthritis&#44; in patients with Castleman&#8217;s disease and in patients with neoplasms<a class="elsevierStyleCrossRefs" href="#bib0110"><span class="elsevierStyleSup">22&#44;29&#44;32&#44;33</span></a> &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#41;&#46; Similarly&#44; in patients with rheumatoid arthritis&#44; tocilizumab reduced hepcidin and improved anaemia&#46;<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3&#44;4</span></a> The same results were obtained in patients with rheumatoid arthritis treated with anti-TNF antibodies&#945; &#40;golimumab or infliximab&#41;&#44; possibly as an indirect result of concomitant suppression of IL-6<a class="elsevierStyleCrossRefs" href="#bib0175"><span class="elsevierStyleSup">35&#44;36</span></a> &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#41;&#46; The main drawback of anti-cytokine therapies is that they generate immunosuppression and an increased risk of infections&#46;<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a></p><p id="par0095" class="elsevierStylePara elsevierViewall">Similar effects have been achieved in cell models and in mice with chemical inhibitors of the IL-6&#47;STAT3 signalling pathway&#44; such as AG490<a class="elsevierStyleCrossRef" href="#bib0185"><span class="elsevierStyleSup">37</span></a> and PpYLKTK&#44; which prevent STAT3 phosphorylation&#46;<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">38</span></a> Both compounds decrease IL6-dependent hepcidin expression in humans&#46;<a class="elsevierStyleCrossRefs" href="#bib0185"><span class="elsevierStyleSup">37&#44;38</span></a> However&#44; the development of these agents as hepcidin inhibitors is hampered either because of a lack of specificity&#44; as happens with all STAT3 inhibitors&#44; or because of poor pharmacokinetics<a class="elsevierStyleCrossRefs" href="#bib0150"><span class="elsevierStyleSup">30&#44;37&#44;38</span></a> &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#41;&#46;</p><p id="par0100" class="elsevierStylePara elsevierViewall">Other hepcidin inhibitors that improve anaemia of chronic diseases&#44; include vitamin D&#44; testosterone&#44; 17-estradiol&#44; and statins which prevent SMAD phosphorylation<a class="elsevierStyleCrossRefs" href="#bib0195"><span class="elsevierStyleSup">39&#8211;42</span></a> &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#41;&#46; In addition&#44; several orally active indazole inhibitors&#44; DS28120313 and DS79182026&#44; have been shown to antagonise the induction of hepcidin in mice injected with IL-6<a class="elsevierStyleCrossRefs" href="#bib0215"><span class="elsevierStyleSup">43&#44;44</span></a> &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#41;&#46; Hepcidin also inhibits SPRC &#40;S-propargyl-cysteine&#41;&#44; an analogue of S-allyl-cysteine&#44; which increases endogenous production of H2S and hydrogen sulfide and blocks the IL-6&#47;JAK2&#47;STAT3 pathway&#44; reducing levels of hepcidin and improving the saturation of tranferrin in vivo&#44; in models of acute and chronic inflammatory anaemia&#46;<a class="elsevierStyleCrossRef" href="#bib0225"><span class="elsevierStyleSup">45</span></a> Also&#44; some plant extracts&#44; such as curcumin&#44; inhibit STAT3 signalling&#44; and consequently&#44; hepcidin levels decrease in humans&#46; This supports the idea that turmeric could be useful in the treatment of anaemia in inflammatory processes<a class="elsevierStyleCrossRef" href="#bib0230"><span class="elsevierStyleSup">46</span></a> &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#41;&#46; Another medicinal plant <span class="elsevierStyleItalic">Caulis spatholobi</span> or <span class="elsevierStyleItalic">jixueteng</span>&#44; has a powerful inhibitory effect on the HAMP expression through the suppression of SMAD 1&#47;5&#47;8 phosphorylation<a class="elsevierStyleCrossRef" href="#bib0235"><span class="elsevierStyleSup">47</span></a> &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#41;&#46;</p></span><span id="sec0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Inhibitors of the BMP6&#47;HJV pathway</span><p id="par0105" class="elsevierStylePara elsevierViewall">The BMP-HJV-SMAD pathway is the other pathway that controls hepcidin synthesis&#44; so its inhibition would decrease HAMP expression and plasma hepcidin levels&#46;<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">19</span></a> HJV has been targeted by several monoclonal antibodies &#40;mAb&#41; &#40;ABT-207&#44; h5F9-AM8 and h5F9-23&#41;&#44; which prevent the binding of BMP with its receptors and block the SMAD pathway&#44; suppress hepcidin and correct anaemia in rats with chronic inflammatory processes<a class="elsevierStyleCrossRefs" href="#bib0240"><span class="elsevierStyleSup">48&#44;49</span></a> &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#41;&#46; Another mAb that blocks the binding of BMP6 with its receptor is LY3113593&#46; It has been tested in CKD patients&#44; achieving a reduction in hepcidin levels&#44; an increase in hemoglobin and a reduction in ferritin&#44; compared to placebo&#46;<a class="elsevierStyleCrossRef" href="#bib0250"><span class="elsevierStyleSup">50</span></a> Likewise&#44; LDN-193189&#44; a dorsomorphine derivative and an inhibitor of BMPR1 in rats and human hepatoma cells has been shown to prevent hepcidin synthesis&#46;<a class="elsevierStyleCrossRef" href="#bib0255"><span class="elsevierStyleSup">51</span></a> The same effect is achieved with a fusion protein that binds soluble HJV &#40;sHJV&#41; and the Fc fragment of the immunoglobulins &#40;sHJV-Fc&#41;&#44; which blocks the binding of BMP with BMPR and prevents the SMAD phosphorylation&#46;<a class="elsevierStyleCrossRefs" href="#bib0090"><span class="elsevierStyleSup">18&#44;52</span></a> Another way to inhibit the BMP pathway is with antisense oligonucleitides&#46; They block hepcidin synthesis regulator genes and RNA interference and are tools for mRNA &#40;siRNA&#41; silencing of the genes that encode hepcidin&#44; TfR2&#44; and HJV<a class="elsevierStyleCrossRefs" href="#bib0255"><span class="elsevierStyleSup">51&#44;53</span></a> &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#41;&#46; Its administration in a mouse model of chronic inflammatory anaemia decreased hepcidin concentrations and corrected anaemia&#46;<a class="elsevierStyleCrossRefs" href="#bib0035"><span class="elsevierStyleSup">7&#44;53</span></a> These agents are effective&#44; but they are not without side effects and are therefore subject to further research&#46;</p><p id="par0110" class="elsevierStylePara elsevierViewall">Heparin binds with high affinity to BMP6 and blocks hepcidin synthesis&#46;<a class="elsevierStyleCrossRef" href="#bib0270"><span class="elsevierStyleSup">54</span></a> In mice and cell lines&#44; it inhibits the phosphorylation of SMAD1&#47;5&#47;8 proteins&#44; caused by the BMPs&#44; and thus decreases the hepcidin expression and increases serum iron&#46; This behaviour is similar to that which occurs in patients treated with heparin to prevent deep vein thrombosis&#46;<a class="elsevierStyleCrossRef" href="#bib0270"><span class="elsevierStyleSup">54</span></a> Its anticoagulant activity limits therapeutic use as a hepcidin inhibitor&#44; but modified heparin analogues have been designed that lack anticoagulant activity&#44; but retain the suppressive property of hepcidin<a class="elsevierStyleCrossRef" href="#bib0270"><span class="elsevierStyleSup">54</span></a> &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#41;&#46;</p><p id="par0115" class="elsevierStylePara elsevierViewall">Recently&#44; erythroferrone has been shown to be a potent competitive inhibitor of BMP6&#46;<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">9</span></a> Therefore&#44; its use to treat anaemia of inflammatory processes that occur with increased hepcidin has been put forward&#46; Any agent that mimics the activity of Erfe would be effective in reducing hepcidin levels&#44; promoting increased serum iron and erythropoiesis&#46;<a class="elsevierStyleCrossRefs" href="#bib0045"><span class="elsevierStyleSup">9&#44;28</span></a></p></span><span id="sec0075" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Neutralisation of circulating hepcidin</span><p id="par0120" class="elsevierStylePara elsevierViewall">Direct inhibitors of hepcidin such as mAbs&#44; anticalins and L-RNA aptamers &#40;called <span class="elsevierStyleItalic">spiegelmers</span>&#44; German for &#171;mirror&#187;&#41;&#44; are effective because they increase the circulating iron&#44; promote erythropoiesis and correct anaemia&#59; these effects are potentiated with EPO in mouse models and in monkeys with ACD&#46;<a class="elsevierStyleCrossRef" href="#bib0275"><span class="elsevierStyleSup">55</span></a> A human anti-hepcidin antibody&#44; 12B9m&#44; has been tested in transgenic mice with inflammatory anaemia caused by <span class="elsevierStyleItalic">Brucella abortus</span> and in monkeys&#46; Neutralisation of hepcidin by mAb increased erythropoiesis and haemoglobin levels<a class="elsevierStyleCrossRef" href="#bib0275"><span class="elsevierStyleSup">55</span></a> &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#41;&#46; Another antihepcidin humanised mAb&#44; LY2787106&#44; improves anaemia in cancer patients by favouring iron mobilisation from the deposits&#46;<a class="elsevierStyleCrossRef" href="#bib0280"><span class="elsevierStyleSup">56</span></a></p><p id="par0125" class="elsevierStylePara elsevierViewall">Anticalins are therapeutic proteins that bind to ligands developed from lipocalins and they can recognise and bind tightly to a wide range of medically relevant targets&#46;<a class="elsevierStyleCrossRef" href="#bib0285"><span class="elsevierStyleSup">57</span></a> In a phase I study and in healthy volunteers&#44; the pegylated anticalin PRS-080 neutralised hepcidin and increased serum iron&#44;<a class="elsevierStyleCrossRef" href="#bib0290"><span class="elsevierStyleSup">58</span></a> which is why a phase II study has been initiated in anaemic patients with CKD<a class="elsevierStyleCrossRef" href="#bib0285"><span class="elsevierStyleSup">57</span></a> &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#41;&#46;</p><p id="par0130" class="elsevierStylePara elsevierViewall">Aptamers &#40;<span class="elsevierStyleItalic">spiegelmers</span>&#41; are designed L-oligoribonucleotides&#44; with a three-dimensional mirror-image form of the target&#44; to which they bind with high affinity&#46; They are stable in the circulation and immunologically passive because their structure contains L-ribose&#44; instead of D-ribose&#44; which gives them a high resistance to nuclease degradation&#46;<a class="elsevierStyleCrossRef" href="#bib0295"><span class="elsevierStyleSup">59</span></a> Lexaptepid &#40;NOX-H94&#41; is an antihepcidin aptamer that inhibits human hepcidin and increases plasma iron and transferrin saturation in human volunteers injected with LPS and in patients with neoplasms<a class="elsevierStyleCrossRef" href="#bib0295"><span class="elsevierStyleSup">59</span></a> &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#41;&#46;</p></span><span id="sec0080" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Blocking the hepcidin-ferroportin interaction</span><p id="par0135" class="elsevierStylePara elsevierViewall">Hepcidin to ferroportin binding occurs in an extracellular region of the ferroportin that contains Cys326 - the sulfhydryl residue&#44; surrounded by hydrophobic residues&#46;<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">17</span></a> Some treatments are aimed at blocking this interaction to prevent the action of hepcidin on ferroportin and facilitate the release of iron into the circulation&#46; An example of these agents is fursultiamine&#44; a thiamine derivative approved by the FDA &#40;<span class="elsevierStyleItalic">Food and Drug Administration</span>&#41;&#44; which blocks the C326 thiol residue of ferroportin&#44; preventing the hepcidin action and aiding the increase in serum iron<a class="elsevierStyleCrossRef" href="#bib0300"><span class="elsevierStyleSup">60</span></a> &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#41;&#46; Another humanised mAb that blocks the binding of hepcidin to ferroportin is LY2928057&#59; in CKD-patients it increases plasma iron&#44; promotes erythropoiesis&#44; corrects anaemia and reduces ferritin levels&#44; compared with placebo&#46;<a class="elsevierStyleCrossRef" href="#bib0245"><span class="elsevierStyleSup">49</span></a></p></span></span><span id="sec0085" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Conclusions</span><p id="par0140" class="elsevierStylePara elsevierViewall">The anaemia of chronic inflammatory processes is common in everyday clinical practice&#46; However&#44; despite the fact that it deteriorates the quality of life of the patient and can negatively affect survival&#44; it is often neglected and not fully assessed by doctors because it is associated with other&#44; usually serious&#44; diseases upon which all therapeutic objectives are focused&#46; In recent years&#44; we have learned about the complex regulation of the iron metabolism&#44; which has allowed us to explore new therapeutic options to correct anaemia&#46; The ultimate goal is to control hepcidin levels&#44; which are ultimately responsible for anaemia&#44; in order to release the iron trapped in the MPS cells&#44; facilitate erythropoiesis&#44; and raise haemoglobin levels&#46; Many therapeutic strategies have emerged thanks to furthering the pathophysiological knowledge on anaemia&#44; derived from and validated in preclinical&#47;clinical studies and in randomised clinical trials&#46; We now have the first effective agents available to control anaemia associated with chronic inflammatory processes&#46;</p></span><span id="sec0090" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Contribution of the authors</span><p id="par0145" class="elsevierStylePara elsevierViewall">RCA&#44; LDE and SCD have equally contributed to the bibliographic review&#44; the writing of the paper and the discussion of its content&#46;</p></span><span id="sec0095" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0115">Ethical responsibilities</span><p id="par0150" class="elsevierStylePara elsevierViewall">It is a review paper in which there are no patients or animals&#46;</p></span><span id="sec0100" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0120">Funding</span><p id="par0155" class="elsevierStylePara elsevierViewall">This work has not received any type of funding&#46;</p></span><span id="sec0105" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0125">Conflict of interest</span><p id="par0160" class="elsevierStylePara elsevierViewall">The authors declare that they have no conflict of interest&#46;</p></span><span id="sec0110" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0130">Thanks</span><p id="par0165" class="elsevierStylePara elsevierViewall">We are grateful to Eulogio Conde Garc&#237;a&#44; retired haematologist and professor of haematology&#44; for the critical review of the paper&#44; as well as his contributions and suggestions&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:16 [
        0 => array:3 [
          "identificador" => "xres1479762"
          "titulo" => "Abstract"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abst0005"
            ]
          ]
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec1347693"
          "titulo" => "Keywords"
        ]
        2 => array:3 [
          "identificador" => "xres1479761"
          "titulo" => "Resumen"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abst0010"
            ]
          ]
        ]
        3 => array:2 [
          "identificador" => "xpalclavsec1347694"
          "titulo" => "Palabras clave"
        ]
        4 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Introduction"
        ]
        5 => array:3 [
          "identificador" => "sec0010"
          "titulo" => "Regulation of iron metabolism"
          "secciones" => array:1 [
            0 => array:2 [
              "identificador" => "sec0015"
              "titulo" => "Regulation of the hepcidin expression"
            ]
          ]
        ]
        6 => array:3 [
          "identificador" => "sec0020"
          "titulo" => "Pathophysiology"
          "secciones" => array:3 [
            0 => array:2 [
              "identificador" => "sec0025"
              "titulo" => "Alteration of iron homeostasis"
            ]
            1 => array:2 [
              "identificador" => "sec0030"
              "titulo" => "Erythropoiesis suppression"
            ]
            2 => array:2 [
              "identificador" => "sec0035"
              "titulo" => "Erythrophagocytosis and a shortened erythrocyte half-life"
            ]
          ]
        ]
        7 => array:2 [
          "identificador" => "sec0040"
          "titulo" => "Diagnosis"
        ]
        8 => array:3 [
          "identificador" => "sec0045"
          "titulo" => "Treatment"
          "secciones" => array:7 [
            0 => array:2 [
              "identificador" => "sec0050"
              "titulo" => "Erythropoiesis potentiation"
            ]
            1 => array:2 [
              "identificador" => "sec0055"
              "titulo" => "Hepcidin antagonists"
            ]
            2 => array:2 [
              "identificador" => "sec0060"
              "titulo" => "Inhibition of hepcidin production"
            ]
            3 => array:2 [
              "identificador" => "sec0065"
              "titulo" => "Suppression of the inflammatory pathway"
            ]
            4 => array:2 [
              "identificador" => "sec0070"
              "titulo" => "Inhibitors of the BMP6&#47;HJV pathway"
            ]
            5 => array:2 [
              "identificador" => "sec0075"
              "titulo" => "Neutralisation of circulating hepcidin"
            ]
            6 => array:2 [
              "identificador" => "sec0080"
              "titulo" => "Blocking the hepcidin-ferroportin interaction"
            ]
          ]
        ]
        9 => array:2 [
          "identificador" => "sec0085"
          "titulo" => "Conclusions"
        ]
        10 => array:2 [
          "identificador" => "sec0090"
          "titulo" => "Contribution of the authors"
        ]
        11 => array:2 [
          "identificador" => "sec0095"
          "titulo" => "Ethical responsibilities"
        ]
        12 => array:2 [
          "identificador" => "sec0100"
          "titulo" => "Funding"
        ]
        13 => array:2 [
          "identificador" => "sec0105"
          "titulo" => "Conflict of interest"
        ]
        14 => array:2 [
          "identificador" => "sec0110"
          "titulo" => "Thanks"
        ]
        15 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2020-05-14"
    "fechaAceptado" => "2020-07-20"
    "PalabrasClave" => array:2 [
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec1347693"
          "palabras" => array:5 [
            0 => "Iron metabolism"
            1 => "Interleukin-6"
            2 => "Hepcidin"
            3 => "Ferroportin"
            4 => "Hepcidin antagonists"
          ]
        ]
      ]
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec1347694"
          "palabras" => array:5 [
            0 => "Metabolismo hierro"
            1 => "Interleucina-6"
            2 => "Hepcidina"
            3 => "Ferroportina"
            4 => "Antagonistas hepcidina"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:2 [
        "titulo" => "Abstract"
        "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Anaemia of chronic disease &#40;ACD&#41; is generated by the activation of the immune system by autoantigens&#44; microbial molecules or tumour antigens resulting in the release of cytokines that cause an elevation of serum hepcidin&#44; hypoferraemia&#44; suppression of erythropoiesis&#44; decrease in erythropoietin &#40;EPO&#41; and shortening of the half-life of red blood cells&#46; Anaemia is usually normocytic and normochromic&#44; which is the most prevalent after iron deficiency anaemia&#44; and it is the most frequent in the elderly and in hospitalized patients&#46; If the anaemia is severe&#44; the patient&#8217;s quality of life deteriorates&#44; and it can have a negative impact on survival&#46; Treatment is aimed at controlling the underlying disease and correcting anaemia&#46; Sometimes intravenous iron and EPO have been used&#44; but the therapeutic future is directed against hepcidin&#44; which is the final target of anaemia&#46;</p></span>"
      ]
      "es" => array:2 [
        "titulo" => "Resumen"
        "resumen" => "<span id="abst0010" class="elsevierStyleSection elsevierViewall"><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">La anemia de las enfermedades cr&#243;nicas &#40;AEC&#41; se genera por la activaci&#243;n del sistema inmune por autoant&#237;genos&#44; mol&#233;culas microbianas o ant&#237;genos tumorales&#44; que dan lugar a la liberaci&#243;n de citocinas que originan una elevaci&#243;n de la hepcidina s&#233;rica&#44; hiposideremia&#44; supresi&#243;n de la eritropoyesis&#44; disminuci&#243;n de la eritropoyetina &#40;EPO&#41; y acortamiento de la vida media de los hemat&#237;es&#46; La anemia suele ser normoc&#237;tica&#47;normocr&#243;mica&#44; es la m&#225;s prevalente&#44; despu&#233;s de la anemia ferrop&#233;nica&#44; y es la m&#225;s frecuente en los ancianos y en los pacientes hospitalizados&#46; Si la anemia es grave&#44; la calidad de vida del paciente se deteriora y puede tener un impacto negativo en la supervivencia&#46; El objetivo del tratamiento va dirigido a controlar la enfermedad de base y a corregir la anemia&#46; En ocasiones se ha utilizado hierro endovenoso y EPO&#44; pero el futuro terap&#233;utico va dirigido contra la hepcidina&#44; que es la diana responsable final de la anemia&#46;</p></span>"
      ]
    ]
    "NotaPie" => array:2 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as&#58; de las Cuevas Allende R&#44; D&#237;az de Entresotos L&#44; Conde D&#237;ez S&#46; Anemia de las enfermedades cr&#243;nicas&#58; fisiopatolog&#237;a&#44; diagn&#243;stico y tratamiento&#46; Med Clin &#40;Barc&#41;&#46; 2021&#59;156&#58;235&#8211;242&#46;</p>"
      ]
      1 => array:3 [
        "etiqueta" => "&#9674;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0010">Both authors have contributed equally as first authors&#46;</p>"
        "identificador" => "fn0005"
      ]
    ]
    "multimedia" => array:5 [
      0 => array:8 [
        "identificador" => "fig0005"
        "etiqueta" => "Fig&#46; 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 2086
            "Ancho" => 2216
            "Tamanyo" => 316839
          ]
        ]
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at0005"
            "detalle" => "Fig&#46; "
            "rol" => "short"
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Synthesis of hepcidin&#46; IL-6 activates the JAK-STAT3 <span class="elsevierStyleItalic">&#40;janus kinase-signal transducer and activator of transcription&#41;</span> signalling pathway&#59; IL1 and activin B &#40;Act-B&#41; increase HAMP transcription through BMP&#47;SMAD signalling&#46; Plasma iron&#44; bound to transferrin &#40;Tf-Fe2&#41; &#40;holo-transferrin&#41;&#44; is a sensor of hepatocytes to regulate hepcidin transcription because it activates the BMP-HJV-SMAD <span class="elsevierStyleItalic">&#40;bone morphogenetic protein-hemojuvelin-small mothers against decapentaplegic</span>&#41; pathway&#46; In hyposideraemia&#44; holo-transferrin binds to the transferrin receptor-1 &#40;TfR1&#41;&#44; the BMP-SMAD pathway is not activated&#44; and the hepcidin is not synthesised&#44; which aids the entry of iron into the plasma&#46; When the hyposideraemia has been resolved&#44; the holo-transferrin binds to the TfR2 receptor and forms a complex with HFE &#40;hereditary hemochromatosis protein&#41;&#44; which activates the BMP pathway in the presence of its receptors &#40;BMPR1 and BMPR2&#41;&#44; of HJV and neogenin &#40;NEO&#41;&#44; promoting the hepcidin synthesis&#46; Erythroferrone &#40;Erfe&#41;&#44; GDF15 &#40;<span class="elsevierStyleItalic">growth differentiation factor&#41;</span> and TWSG1 &#40;<span class="elsevierStyleItalic">twisted gastrulation BMP signalling modulator</span>&#41; inhibit hepcidin synthesis by blocking the SMAD pathway&#46; Another inhibitor of hepcidin is matriptase-2 &#40;MT-2&#41;&#44; which blocks HJV by preventing the activation of the BMP complex&#46; Tissue hypoxia and erythropoietin also inhibit hepcidin synthesis&#46;</p>"
        ]
      ]
      1 => array:8 [
        "identificador" => "fig0010"
        "etiqueta" => "Fig&#46; 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 1841
            "Ancho" => 1667
            "Tamanyo" => 158308
          ]
        ]
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at0010"
            "detalle" => "Fig&#46; "
            "rol" => "short"
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Pathophysiology of ACD&#46;</p> <p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">ACD&#58; Anaemia of chronic diseases or inflammatory anaemia&#59; IL&#58; Interleukin&#59; EPO&#58; Erythropoietin&#59; Fe&#58; Serum iron&#59; MPS&#58; Mononuclear phagocyte system&#46;</p>"
        ]
      ]
      2 => array:8 [
        "identificador" => "fig0015"
        "etiqueta" => "Fig&#46; 3"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr3.jpeg"
            "Alto" => 1979
            "Ancho" => 2167
            "Tamanyo" => 351992
          ]
        ]
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at0015"
            "detalle" => "Fig&#46; "
            "rol" => "short"
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Physiopathological mechanisms of anaemia in chronic diseases&#46; In inflammatory processes&#44; the cytokines &#40;IL-6&#44; IL-1&#44; IL-22&#44; lipopolysaccharides &#91;LPS&#93;&#44; interferon-&#947; &#91;IFN-&#947;&#93;&#44; and tumour necrosis factor alpha &#91;TNF&#945;&#93;&#41; increase&#44; and are responsible for the increase in hepcidin&#46; The hepcidin blocks the ferroportin &#40;FPN&#41; of the enterocytes&#44; macrophages&#44; and hepatocytes&#44; leading to hyposideraemia&#44; and the accumulation of iron in macrophages&#44; in the form of ferritin&#46; The cytokines activate the macrophages&#44; facilitating erythrophagocytosis and also decrease the renal EPO production and prevent hemoglobinisation of erythroblasts&#46; Hyposideraemia plays a central role in the suppression of erythropoiesis because there is no transfer of iron to the erythroblasts through the transferrin receptor &#40;R-Tf&#41;&#46; Erythropoiesis is also inhibited by the decrease in renal EPO and the reduced expression of the EPO receptor &#40;EPOR&#41;&#44; due to the action of cytokines and the lack of iron that prevents the synthesis of a regulator called <span class="elsevierStyleItalic">scribble</span> &#40;SCB&#41;&#46; In turn&#44; the suppression of erythropoiesis has a negative impact on the hepcidin blockers&#44; ERFE&#44; GDF15 and TWSG1&#46;</p>"
        ]
      ]
      3 => array:8 [
        "identificador" => "fig0020"
        "etiqueta" => "Fig&#46; 4"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr4.jpeg"
            "Alto" => 1527
            "Ancho" => 1667
            "Tamanyo" => 160291
          ]
        ]
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at0020"
            "detalle" => "Fig&#46; "
            "rol" => "short"
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Diagnostic algorithm for normocytic anaemias in chronic diseases&#46; ACD&#58; Anaemia of chronic disease&#46;</p>"
        ]
      ]
      4 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Table 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at0025"
            "detalle" => "Table "
            "rol" => "short"
          ]
        ]
        "tabla" => array:1 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Inhibitor&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Action and target&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">References&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " colspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Inhibition of hepcidin synthesis</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic"><span class="elsevierStyleHsp" style=""></span>IL6&#47;STAT3 pathway</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Anti-IL6 &#40;siltuximab&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">IL6 sequestration&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><a class="elsevierStyleCrossRef" href="#bib0105">&#91;21&#93;</a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Anti-IL6r &#40;tocilizumab&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">IL6 receptor sequestration&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><a class="elsevierStyleCrossRefs" href="#bib0110">&#91;22&#44;34&#93;</a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Momelotinib&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">JAK 1&#47;2 inhibitor&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><a class="elsevierStyleCrossRefs" href="#bib0145">&#91;29&#44;30&#93;</a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>mAb TNF-&#9001; &#40;infliximab&#44; golimumab&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Indirect effect of IL-6 suppression&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><a class="elsevierStyleCrossRefs" href="#bib0175">&#91;35&#44;36&#93;</a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>DS28120313&#44; DS79182026&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">IL6-induced low hepcidin in mice&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><a class="elsevierStyleCrossRefs" href="#bib0215">&#91;43&#44;44&#93;</a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>S-Propargyl-Cystene&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Blocks IL6&#47;JAK2&#47;STAT3 pathway&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><a class="elsevierStyleCrossRef" href="#bib0225">&#91;45&#93;</a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>AG490&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">STAT3 phosphorylation inhibitor&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><a class="elsevierStyleCrossRefs" href="#bib0185">&#91;37&#44;38&#93;</a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>PpYLKTK&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Prevents STAT3 dimerisation&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><a class="elsevierStyleCrossRef" href="#bib0190">&#91;38&#93;</a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">BMPs&#47;BMPR&#47;HJV pathway</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Anti-HJV mAb &#40;ABT-207&#44; h5F9-AM8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">BMPs&#47;SMAD path inhibitor&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><a class="elsevierStyleCrossRefs" href="#bib0240">&#91;48&#44;49&#93;</a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>LY3113593 mAb&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Blocks the binding of BMP6 to its receptor&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><a class="elsevierStyleCrossRef" href="#bib0250">&#91;50&#93;</a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>HJVs-Fc &#40;FMX-8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">BMPs&#47;SMAD path inhibitor&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><a class="elsevierStyleCrossRefs" href="#bib0090">&#91;18&#44;52&#93;</a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>LDN-193189&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">BMPR1 phosphorylation inhibitor&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><a class="elsevierStyleCrossRef" href="#bib0255">&#91;51&#93;</a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Anti-MBP6 mAb&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">BMP6 sequestration&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><a class="elsevierStyleCrossRefs" href="#bib0035">&#91;7&#44;18&#93;</a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>siHep&#44; siHJV&#44; siTfR2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Degradation of the mRNA of hepcidin&#44; HJV or TfR2 inhibitors of the BMPs&#47;SMAD pathway&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><a class="elsevierStyleCrossRefs" href="#bib0090">&#91;18&#44;52&#44;53&#93;</a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Modified heparin&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><a class="elsevierStyleCrossRef" href="#bib0270">&#91;54&#93;</a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " colspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Antihepcidin agents</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Antihepcidin mAb &#40;12B9m&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Hepcidin protein sequestration&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><a class="elsevierStyleCrossRefs" href="#bib0095">&#91;19&#44;55&#93;</a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Antihepcidin mAb &#40;LY2787106&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Hepcidin protein sequestration&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><a class="elsevierStyleCrossRef" href="#bib0280">&#91;56&#93;</a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Spiegelmer NOX-H94 &#40;lexaptepid&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Hepcidin protein sequestration&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><a class="elsevierStyleCrossRef" href="#bib0295">&#91;59&#93;</a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Pegylated anticalin &#40;PRS-080&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Hepcidin protein sequestration&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><a class="elsevierStyleCrossRefs" href="#bib0285">&#91;57&#44;58&#93;</a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " colspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Hepcidin-ferroportin interaction</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Antiferroportin mAb &#40;LY2928057&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Interferes with hepcidin-ferroportin &#40;FPN&#41; binding&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><a class="elsevierStyleCrossRef" href="#bib0250">&#91;50&#93;</a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Fursultiamine</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Cys326-HS sequestration &#40;FPN-hepcidin binding&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><a class="elsevierStyleCrossRef" href="#bib0300">&#91;60&#93;</a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " colspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Other inhibitors</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>1&#44;25<span class="elsevierStyleItalic">-dihydroxyvitamin D</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Suppresses SMAD 1&#47;5&#47;8 phosphorylation&#46; Vitamin D receptor&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><a class="elsevierStyleCrossRef" href="#bib0195">&#91;39&#93;</a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Testosterone</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Suppresses SMAD 1&#47;5&#47;8 phosphorylation&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><a class="elsevierStyleCrossRef" href="#bib0200">&#91;40&#93;</a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">17-estradiol</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Suppresses SMAD 1&#47;5&#47;8 phosphorylation&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><a class="elsevierStyleCrossRef" href="#bib0205">&#91;41&#93;</a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Statins</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Decreased hepcidin - anti-inflammatory action&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><a class="elsevierStyleCrossRef" href="#bib0210">&#91;42&#93;</a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Curcumin</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Blocks STAT3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><a class="elsevierStyleCrossRef" href="#bib0230">&#91;46&#93;</a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Chinese medicinal plant&#58;</span> Caulis spatholobi &#40;jixueteng&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Suppresses SMAD 1&#47;5&#47;8 phosphorylation&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><a class="elsevierStyleCrossRef" href="#bib0235">&#91;47&#93;</a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab2546365.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Hepcidin inhibitors and their corresponding targets&#46;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:60 [
            0 => array:3 [
              "identificador" => "bib0005"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Anemia of inflammation"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "T&#46; Ganz"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMra1804281"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2019"
                        "volumen" => "381"
                        "paginaInicial" => "1148"
                        "paginaFinal" => "1157"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31532961"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0010"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Anemia del anciano"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "S&#46; G&#243;mez Ram&#237;rez"
                            1 => "A&#46;R&#46; Remacha Sevilla"
                            2 => "M&#46; Mu&#241;oz G&#243;mez"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.medcli.2017.06.025"
                      "Revista" => array:5 [
                        "tituloSerie" => "Med Clin &#40;Barc&#41;"
                        "fecha" => "2017"
                        "volumen" => "149"
                        "paginaInicial" => "496"
                        "paginaFinal" => "503"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0015"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Anemia of inflammation"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "G&#46; Weiss"
                            1 => "T&#46; Ganz"
                            2 => "L&#46;T&#46; Goodnough"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1182/blood-2018-06-856500"
                      "Revista" => array:6 [
                        "tituloSerie" => "Blood"
                        "fecha" => "2019"
                        "volumen" => "133"
                        "paginaInicial" => "40"
                        "paginaFinal" => "50"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30401705"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0020"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Estado actual del metabolismo del hierro&#58; implicaciones cl&#237;nicas y terap&#233;uticas"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "S&#46; Conde Diez"
                            1 => "R&#46; de las Cuevas Allende"
                            2 => "E&#46; Conde Garc&#237;a"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Med Clin &#40;Barc&#41;"
                        "fecha" => "2017"
                        "volumen" => "148"
                        "paginaInicial" => "218"
                        "paginaFinal" => "224"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0025"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Hepcidin and anemia&#58; a tight relationship"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "A&#46; Pagani"
                            1 => "A&#46; Nai"
                            2 => "L&#46; Silvestri"
                            3 => "C&#46; Camaschella"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.3389/fphys.2019.01294"
                      "Revista" => array:5 [
                        "tituloSerie" => "Front Physiol"
                        "fecha" => "2019"
                        "volumen" => "10"
                        "paginaInicial" => "1294"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31649559"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0030"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Hepcidin regulation in the anemia of inflammation"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "C&#46;Y&#46; Wang"
                            1 => "J&#46;L&#46; Babitt"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/MOH.0000000000000236"
                      "Revista" => array:6 [
                        "tituloSerie" => "Curr Opin Hematol"
                        "fecha" => "2016"
                        "volumen" => "23"
                        "paginaInicial" => "189"
                        "paginaFinal" => "197"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26886082"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0035"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Hepcidin therapeutics"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "A&#46; Katsarou"
                            1 => "K&#46; Pantopoulos"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.3390/ph11040127"
                      "Revista" => array:4 [
                        "tituloSerie" => "Pharmaceuticals &#40;Basel&#41;"
                        "fecha" => "2018"
                        "volumen" => "11"
                        "paginaInicial" => "127"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0040"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "HFE interacts with the BMP type I receptor ALK3 to regulate hepcidin expression"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "X&#46;G&#46; Wu"
                            1 => "Y&#46; Wang"
                            2 => "Q&#46; Wu"
                            3 => "W&#46;H&#46; Cheng"
                            4 => "W&#46; Liu"
                            5 => "Y&#46; Zhao"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1182/blood-2014-01-552281"
                      "Revista" => array:6 [
                        "tituloSerie" => "Blood"
                        "fecha" => "2014"
                        "volumen" => "124"
                        "paginaInicial" => "1335"
                        "paginaFinal" => "1343"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24904118"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0045"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Erythroferrone inhibits the induction of hepcidin by BMP6"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46; Arezes"
                            1 => "N&#46; Foy"
                            2 => "K&#46; McHugh"
                            3 => "A&#46; Sawant"
                            4 => "D&#46; Quinkert"
                            5 => "V&#46; Terraube"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1182/blood-2018-06-857995"
                      "Revista" => array:6 [
                        "tituloSerie" => "Blood"
                        "fecha" => "2018"
                        "volumen" => "132"
                        "paginaInicial" => "1473"
                        "paginaFinal" => "1477"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30097509"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0050"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Erythroferrone lowers hepcidin by sequestering BMP2&#47;6 heterodimer from binding to the BMP type I receptor ALK3"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46;Y&#46; Wang"
                            1 => "Y&#46; Xu"
                            2 => "L&#46; Traeger"
                            3 => "D&#46;Y&#46; Dogan"
                            4 => "X&#46; Xiao"
                            5 => "A&#46;U&#46; Steinbicker"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1182/blood.2019002620"
                      "Revista" => array:6 [
                        "tituloSerie" => "Blood"
                        "fecha" => "2020"
                        "volumen" => "135"
                        "paginaInicial" => "453"
                        "paginaFinal" => "456"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31800957"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Matriptase-2 suppresses hepcidin expression by cleaving multiple components of the hepcidin induction pathway"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Wahedi"
                            1 => "A&#46;M&#46; Wortham"
                            2 => "M&#46;D&#46; Kleven"
                            3 => "N&#46; Zhao"
                            4 => "S&#46; Jue"
                            5 => "C&#46;A&#46; Enns"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1074/jbc.M117.801795"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Biol Chem"
                        "fecha" => "2017"
                        "volumen" => "292"
                        "paginaInicial" => "18354"
                        "paginaFinal" => "18371"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28924039"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "12"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "New insights into iron regulation and erythropoiesis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "A&#46; Kim"
                            1 => "E&#46; Nemeth"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/MOH.0000000000000132"
                      "Revista" => array:6 [
                        "tituloSerie" => "Curr Opin Hematol"
                        "fecha" => "2015"
                        "volumen" => "22"
                        "paginaInicial" => "199"
                        "paginaFinal" => "205"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25710710"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib0065"
              "etiqueta" => "13"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Anemia of inflammation with an emphasis on chronic kidney disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "S&#46; Begum"
                            1 => "G&#46;O&#46; Latunde-Dada"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "tituloSerie" => "Nutrients"
                        "fecha" => "2019"
                        "volumen" => "11"
                        "paginaInicial" => "2424"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib0070"
              "etiqueta" => "14"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Iron modulation of erythropoiesis is associated with Scribble-mediated control of the erythropoietin receptor"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "S&#46; Khalil"
                            1 => "L&#46; Delehanty"
                            2 => "S&#46; Grado"
                            3 => "M&#46; Holy"
                            4 => "I&#46;I&#46;I&#46;Z&#46; White"
                            5 => "K&#46; Freeman"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1084/jem.20170396"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Exp Med"
                        "fecha" => "2018"
                        "volumen" => "215"
                        "paginaInicial" => "661"
                        "paginaFinal" => "679"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29282252"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib0075"
              "etiqueta" => "15"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A long sought after &#8220;receptor&#8221; for ERFE&#63;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "A&#46;S&#46; Zhang"
                            1 => "C&#46;A&#46; Enns"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1182/blood-2018-08-869586"
                      "Revista" => array:6 [
                        "tituloSerie" => "Blood"
                        "fecha" => "2018"
                        "volumen" => "132"
                        "paginaInicial" => "1463"
                        "paginaFinal" => "1464"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30287465"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib0080"
              "etiqueta" => "16"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Diagnostics in anaemia of chronic disease in general practice&#58; a real-world retrospective cohort study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46; Schop"
                            1 => "K&#46; Stouten"
                            2 => "R&#46; van Houten"
                            3 => "J&#46; Riedl"
                            4 => "J&#46; van Rosmalen"
                            5 => "P&#46;J&#46;E&#46; Bindels"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.3399/bjgpopen18X101597"
                      "Revista" => array:3 [
                        "tituloSerie" => "BJGP Open"
                        "fecha" => "2018"
                        "volumen" => "2"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            16 => array:3 [
              "identificador" => "bib0085"
              "etiqueta" => "17"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Anemia of inflammation"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "E&#46; Nemeth"
                            1 => "T&#46; Ganz"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.hoc.2014.04.005"
                      "Revista" => array:6 [
                        "tituloSerie" => "Hematol Oncol Clin North Am"
                        "fecha" => "2014"
                        "volumen" => "28"
                        "paginaInicial" => "671"
                        "paginaFinal" => "681"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25064707"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            17 => array:3 [
              "identificador" => "bib0090"
              "etiqueta" => "18"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Hepcidin&#58; a promising therapeutic target for iron disorders&#46; A systematic review"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "J&#46; Liu"
                            1 => "B&#46; Sun"
                            2 => "H&#46; Yin"
                            3 => "S&#46; Liu"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "tituloSerie" => "Medicine &#40;Baltimore&#41;"
                        "fecha" => "2016"
                        "volumen" => "95"
                        "paginaInicial" => "e3150"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            18 => array:3 [
              "identificador" => "bib0095"
              "etiqueta" => "19"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Pharmacodynamic model of hepcidin regulation of iron homeostasis in cynomolgus monkeys"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "W&#46; Krzyzanski"
                            1 => "J&#46;J&#46; Xiao"
                            2 => "B&#46; Sasu"
                            3 => "B&#46; Hinkle"
                            4 => "J&#46;J&#46; Perez-Ruixo"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1208/s12248-016-9886-1"
                      "Revista" => array:6 [
                        "tituloSerie" => "AAPS J"
                        "fecha" => "2016"
                        "volumen" => "18"
                        "paginaInicial" => "713"
                        "paginaFinal" => "727"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26917226"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            19 => array:3 [
              "identificador" => "bib0100"
              "etiqueta" => "20"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "therapeutic advances in regulating the hepcidin&#47;ferroportin axis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "Z&#46;J&#46; Hawula"
                            1 => "D&#46;F&#46; Wallace"
                            2 => "N&#46; V&#46; Subramaniam"
                            3 => "G&#46; Rishi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "tituloSerie" => "Pharmaceuticals"
                        "fecha" => "2019"
                        "volumen" => "12"
                        "paginaInicial" => "170"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            20 => array:3 [
              "identificador" => "bib0105"
              "etiqueta" => "21"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Targeting interleukin-6&#58; all the way to treat autoimmune and inflammatory diseases"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "T&#46; Tanaka"
                            1 => "T&#46; Kishimoto"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.7150/ijbs.4666"
                      "Revista" => array:6 [
                        "tituloSerie" => "Int J Biol Sci"
                        "fecha" => "2012"
                        "volumen" => "8"
                        "paginaInicial" => "1227"
                        "paginaFinal" => "1236"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23136551"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            21 => array:3 [
              "identificador" => "bib0110"
              "etiqueta" => "22"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Analysis of inflammatory and anemia-related biomarkers in a randomized&#44; double-blind&#44; placebo-controlled study of siltuximab &#40;anti-IL6 monoclonal antibody&#41; in patients with multicentric castleman disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46; Casper"
                            1 => "S&#46; Chaturvedi"
                            2 => "N&#46; Munshi"
                            3 => "R&#46; Wong"
                            4 => "M&#46; Qi"
                            5 => "M&#46; Schaffer"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1158/1078-0432.CCR-15-0134"
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Cancer Res"
                        "fecha" => "2015"
                        "volumen" => "21"
                        "paginaInicial" => "4294"
                        "paginaFinal" => "4304"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26124203"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            22 => array:3 [
              "identificador" => "bib0115"
              "etiqueta" => "23"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Prolyl hydroxylase inhibition corrects functional iron deficiency and inflammation-induced anaemia in rats"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "T&#46;D&#46; Barrett"
                            1 => "H&#46;L&#46; Palomino"
                            2 => "T&#46;I&#46; Brondstetter"
                            3 => "K&#46;C&#46; Kanelakis"
                            4 => "X&#46; Wu"
                            5 => "W&#46; Yan"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/bph.13188"
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Pharmacol"
                        "fecha" => "2015"
                        "volumen" => "172"
                        "paginaInicial" => "4078"
                        "paginaFinal" => "4088"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25988595"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            23 => array:3 [
              "identificador" => "bib0120"
              "etiqueta" => "24"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Hypoxia-inducible factor and its role in the management of anemia in chronic kidney disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "J&#46; Kaplan"
                            1 => "N&#46; Sharma"
                            2 => "S&#46; Dikdan"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "tituloSerie" => "Int J Mol Sci"
                        "fecha" => "2018"
                        "volumen" => "19"
                        "paginaInicial" => "389"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            24 => array:3 [
              "identificador" => "bib0125"
              "etiqueta" => "25"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "First-in-man&#8211;proof of concept study with molidustat&#58; a novel selective oral FIH-prolyl hydroxylase inhibitor for the treatment of renal anaemia"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; B&#246;ttcher"
                            1 => "S&#46; Lentini"
                            2 => "E&#46;R&#46; Arens"
                            3 => "A&#46; Kaiser"
                            4 => "D&#46; van der Mey"
                            5 => "U&#46; Thuss"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/bcp.13584"
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Clin Pharmacol"
                        "fecha" => "2018"
                        "volumen" => "84"
                        "paginaInicial" => "1557"
                        "paginaFinal" => "1565"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29575006"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            25 => array:3 [
              "identificador" => "bib0130"
              "etiqueta" => "26"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Roxadustat for anemia in patients with kidney disease not receiving dialysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "N&#46; Chen"
                            1 => "C&#46; Hao"
                            2 => "X&#46; Peng"
                            3 => "H&#46; Lin"
                            4 => "A&#46; Yin"
                            5 => "L&#46; Hao"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa1813599"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2019"
                        "volumen" => "381"
                        "paginaInicial" => "1001"
                        "paginaFinal" => "1010"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31340089"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            26 => array:3 [
              "identificador" => "bib0135"
              "etiqueta" => "27"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Roxadustat treatment for anemia in patients undergoing long-term dialysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "N&#46; Chen"
                            1 => "C&#46; Hao"
                            2 => "B&#46;-C&#46; Liu"
                            3 => "H&#46; Lin"
                            4 => "C&#46; Wang"
                            5 => "C&#46; Xing"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa1901713"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2019"
                        "volumen" => "381"
                        "paginaInicial" => "1011"
                        "paginaFinal" => "1022"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31340116"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            27 => array:3 [
              "identificador" => "bib0140"
              "etiqueta" => "28"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Erythropoietic regulators of iron metabolism"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "T&#46; Ganz"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Free Radic Biol Med"
                        "fecha" => "2019"
                        "volumen" => "33"
                        "paginaInicial" => "69"
                        "paginaFinal" => "74"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            28 => array:3 [
              "identificador" => "bib0145"
              "etiqueta" => "29"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody &#40;tocilizumab&#41; improves anemia of inflammation in multicentric Castleman disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "S&#46;N&#46; Song"
                            1 => "N&#46; Tomosugi"
                            2 => "H&#46; Kawabata"
                            3 => "T&#46; Ishikawa"
                            4 => "T&#46; Nishikawa"
                            5 => "K&#46; Yoshizaki"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1182/blood-2010-03-271791"
                      "Revista" => array:6 [
                        "tituloSerie" => "Blood"
                        "fecha" => "2010"
                        "volumen" => "116"
                        "paginaInicial" => "3627"
                        "paginaFinal" => "3634"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20644113"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            29 => array:3 [
              "identificador" => "bib0150"
              "etiqueta" => "30"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Momelotinib inhibits ACVR1&#47;ALK2&#44; decreases hepcidin production&#44; and ameliorates anemia of chronic disease in rodents"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Asshoff"
                            1 => "V&#46; Petzer"
                            2 => "M&#46;R&#46; Warr"
                            3 => "D&#46; Haschka"
                            4 => "P&#46; Tymoszuk"
                            5 => "E&#46; Demetz"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1182/blood-2016-09-740092"
                      "Revista" => array:6 [
                        "tituloSerie" => "Blood"
                        "fecha" => "2017"
                        "volumen" => "129"
                        "paginaInicial" => "1823"
                        "paginaFinal" => "1830"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28188131"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            30 => array:3 [
              "identificador" => "bib0155"
              "etiqueta" => "31"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "SIMPLIFY-1&#58; a phase III randomized trial of momelotinib versus ruxolitinib in Janus kinase inhibitor-na&#239;ve patients with myelofibrosis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "R&#46;A&#46; Mesa"
                            1 => "J&#46;J&#46; Kiladjian"
                            2 => "J&#46;V&#46; Catalano"
                            3 => "T&#46; Devos"
                            4 => "M&#46; Egyed"
                            5 => "A&#46; Hellmann"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1200/JCO.2017.73.4418"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Clin Oncol"
                        "fecha" => "2017"
                        "volumen" => "35"
                        "paginaInicial" => "3844"
                        "paginaFinal" => "3850"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28930494"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            31 => array:3 [
              "identificador" => "bib0160"
              "etiqueta" => "32"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Treatment with anti-IL-6 receptor antibody prevented increase in serum hepcidin levels and improved anemia in mice inoculated with IL-6&#8211;producing lung carcinoma cells"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "M&#46; Noguchi-Sasaki"
                            1 => "Y&#46; Sasaki"
                            2 => "Y&#46; Shimonaka"
                            3 => "K&#46; Mori"
                            4 => "K&#46; Fujimoto-Ouchi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1186/s12885-016-2305-2"
                      "Revista" => array:5 [
                        "tituloSerie" => "BMC Cancer"
                        "fecha" => "2016"
                        "volumen" => "16"
                        "paginaInicial" => "270"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27068103"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            32 => array:3 [
              "identificador" => "bib0165"
              "etiqueta" => "33"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Role of hepcidin-ferroportin axis in the pathophysiology&#44; diagnosis&#44; and treatment of anemia of chronic inflammation"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "A&#46;L&#46; Langer"
                            1 => "Y&#46;Z&#46; Ginzburg"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/hdi.12543"
                      "Revista" => array:6 [
                        "tituloSerie" => "Hemodial Int"
                        "fecha" => "2017"
                        "volumen" => "21"
                        "paginaInicial" => "S37"
                        "paginaFinal" => "S46"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28328181"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            33 => array:3 [
              "identificador" => "bib0170"
              "etiqueta" => "34"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Tocilizumab for treating rheumatoid arthritis&#58; an evaluation of pharmacokinetics&#47;pharmacodynamics and clinical efficacy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "S&#46;N&#46; Song"
                            1 => "K&#46; Yoshizaki"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1517/17425255.2015.992779"
                      "Revista" => array:6 [
                        "tituloSerie" => "Expert Opin Drug Metab Toxicol"
                        "fecha" => "2015"
                        "volumen" => "11"
                        "paginaInicial" => "307"
                        "paginaFinal" => "316"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25491492"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            34 => array:3 [
              "identificador" => "bib0175"
              "etiqueta" => "35"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Effects of subcutaneous and intravenous golimumab on inflammatory biomarkers in patients with rheumatoid arthritis&#58; results of a phase 1&#44; randomized&#44; open-label trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46;K&#46; Doyle"
                            1 => "M&#46;U&#46; Rahman"
                            2 => "B&#46; Frederick"
                            3 => "C&#46;A&#46; Birbara"
                            4 => "D&#46; de Vries"
                            5 => "G&#46; Teodter"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1093/rheumatology/kes381"
                      "Revista" => array:6 [
                        "tituloSerie" => "Rheumatology"
                        "fecha" => "2013"
                        "volumen" => "52"
                        "paginaInicial" => "1214"
                        "paginaFinal" => "1219"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23418046"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            35 => array:3 [
              "identificador" => "bib0180"
              "etiqueta" => "36"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Anti-TNF-&#945; effects on anemia in rheumatoid and psoriatic arthritis&#46; et al&#46;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "A&#46; Corrado"
                            1 => "V&#46; Di Bello"
                            2 => "F&#46; d&#8217;Onofrio"
                            3 => "N&#46; Maruotti"
                            4 => "F&#46;P&#46; Cantatore"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1177/0394632017714695"
                      "Revista" => array:6 [
                        "tituloSerie" => "Int J Immunopathol Pharmacol"
                        "fecha" => "2017"
                        "volumen" => "30"
                        "paginaInicial" => "302"
                        "paginaFinal" => "307"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28604144"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            36 => array:3 [
              "identificador" => "bib0185"
              "etiqueta" => "37"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "AG490&#58; an inhibitor of hepcidin expression in vivo"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "S&#46;P&#46; Zhang"
                            1 => "Z&#46; Wang"
                            2 => "L&#46;X&#46; Wang"
                            3 => "S&#46;J&#46; Liu"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "World J Gastroenterol"
                        "fecha" => "2011"
                        "volumen" => "17"
                        "paginaInicial" => "5032"
                        "paginaFinal" => "5034"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            37 => array:3 [
              "identificador" => "bib0190"
              "etiqueta" => "38"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Natural and synthetic STAT3 inhibitors reduce hepcidin expression in differentiated mouse hepatocytes expressing the active phosphorylated STAT3 form"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "N&#46; Fatih"
                            1 => "E&#46; Camberlein"
                            2 => "M&#46;L&#46; Island"
                            3 => "A&#46; Corlu"
                            4 => "E&#46; Abgueguen"
                            5 => "L&#46; D&#233;tivaud"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "J Mol Med &#40;Berl&#41;"
                        "fecha" => "2010"
                        "volumen" => "88"
                        "paginaInicial" => "477"
                        "paginaFinal" => "486"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            38 => array:3 [
              "identificador" => "bib0195"
              "etiqueta" => "39"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Suppression of iron-regulatory hepcidin by vitamin D"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46; Bacchetta"
                            1 => "J&#46;J&#46; Zaritsky"
                            2 => "J&#46;L&#46; Sea"
                            3 => "R&#46;F&#46; Chun"
                            4 => "T&#46;S&#46; Lisse"
                            5 => "K&#46; Zavala"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1681/ASN.2013040355"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Am Soc Nephrol"
                        "fecha" => "2014"
                        "volumen" => "25"
                        "paginaInicial" => "564"
                        "paginaFinal" => "572"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24204002"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            39 => array:3 [
              "identificador" => "bib0200"
              "etiqueta" => "40"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Effects of testosterone on erythropoiesis in a female mouse model of anemia of inflammation"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "W&#46; Guo"
                            1 => "P&#46;J&#46; Schmidt"
                            2 => "M&#46;D&#46; Fleming"
                            3 => "S&#46; Bhasin"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1210/en.2016-1150"
                      "Revista" => array:6 [
                        "tituloSerie" => "Endocrinology"
                        "fecha" => "2016"
                        "volumen" => "157"
                        "paginaInicial" => "2937"
                        "paginaFinal" => "2946"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27074351"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            40 => array:3 [
              "identificador" => "bib0205"
              "etiqueta" => "41"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "17&#946;-Estradiol inhibits iron hormone hepcidin through an estrogen responsive element half-site"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "Q&#46; Yang"
                            1 => "J&#46; Jian"
                            2 => "S&#46; Katz"
                            3 => "S&#46;B&#46; Abramson"
                            4 => "X&#46; Huang"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1210/en.2011-2045"
                      "Revista" => array:6 [
                        "tituloSerie" => "Endocrinology"
                        "fecha" => "2012"
                        "volumen" => "153"
                        "paginaInicial" => "3170"
                        "paginaFinal" => "3178"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22535765"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            41 => array:3 [
              "identificador" => "bib0210"
              "etiqueta" => "42"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Effect of atorvastatin on iron metabolism regulation in patients with chronic kidney disease &#8211; a randomized double blind crossover study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "A&#46; Masajtis-Zagajewska"
                            1 => "M&#46; Nowicki"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Renal Failure"
                        "fecha" => "2018"
                        "volumen" => "40"
                        "paginaInicial" => "701"
                        "paginaFinal" => "710"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            42 => array:3 [
              "identificador" => "bib0215"
              "etiqueta" => "43"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Discovery of DS28120313 as a potent orally active hepcidin production inhibitor&#58; desing and optimization of novel 4&#44;6-disubstituted indazole derivatives"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "T&#46; Fukuda"
                            1 => "R&#46; Goto"
                            2 => "T&#46; Kiho"
                            3 => "K&#46; Ueda"
                            4 => "S&#46; Muramatsu"
                            5 => "M&#46; Hashimoto"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.bmcl.2017.10.031"
                      "Revista" => array:6 [
                        "tituloSerie" => "Bioorg Med Chem Lett"
                        "fecha" => "2017"
                        "volumen" => "27"
                        "paginaInicial" => "5252"
                        "paginaFinal" => "5257"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29079471"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            43 => array:3 [
              "identificador" => "bib0220"
              "etiqueta" => "44"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Discovery of DS79182026&#58; a potent orally active hepcidin production inhibitor"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "T&#46; Fukuda"
                            1 => "R&#46; Goto"
                            2 => "T&#46; Kiho"
                            3 => "K&#46; Ueda"
                            4 => "S&#46; Muramatsu"
                            5 => "M&#46; Hashimoto"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.bmcl.2017.07.004"
                      "Revista" => array:6 [
                        "tituloSerie" => "Bioorg Med Chem Lett"
                        "fecha" => "2017"
                        "volumen" => "27"
                        "paginaInicial" => "3716"
                        "paginaFinal" => "3722"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28705644"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            44 => array:3 [
              "identificador" => "bib0225"
              "etiqueta" => "45"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "S-Propargyl-Cysteine&#44; a novel hydrogen sulfide donor&#44; inhibits inflammatory hepcidin and relieves anemia of inflammation by inhibiting IL-6&#47;STAT3 pathway"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "M&#46; Wang"
                            1 => "W&#46; Tang"
                            2 => "H&#46; Xin"
                            3 => "Y&#46;Z&#46; Zhu"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1371/journal.pone.0163289"
                      "Revista" => array:4 [
                        "tituloSerie" => "PLoS One"
                        "fecha" => "2016"
                        "volumen" => "11"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28002457"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            45 => array:3 [
              "identificador" => "bib0230"
              "etiqueta" => "46"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Curcuma decreases serum hepcidin levels in healthy volunteers&#58; a placebo-controlled&#44; randomized&#44; double-blind&#44; cross-over study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "F&#46; Lain&#233;"
                            1 => "B&#46; Laviolle"
                            2 => "E&#46; Bardou-Jacquet"
                            3 => "N&#46; Fatih"
                            4 => "C&#46; Jezequel"
                            5 => "N&#46; Collet"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/fcp.12288"
                      "Revista" => array:6 [
                        "tituloSerie" => "Fundam Clin Pharmacol"
                        "fecha" => "2017"
                        "volumen" => "31"
                        "paginaInicial" => "567"
                        "paginaFinal" => "573"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28370178"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            46 => array:3 [
              "identificador" => "bib0235"
              "etiqueta" => "47"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Screening identifies the Chinese medicinal plant caulis spatholobi as an effective HAMP expression inhibitor"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "Y&#46; Guan"
                            1 => "P&#46; An"
                            2 => "Z&#46; Zhang"
                            3 => "F&#46; Zhang"
                            4 => "Y&#46; Tu"
                            5 => "Q&#46; Wu"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.3945/jn.113.174201"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Nutr"
                        "fecha" => "2013"
                        "volumen" => "143"
                        "paginaInicial" => "1061"
                        "paginaFinal" => "1066"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23700338"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            47 => array:3 [
              "identificador" => "bib0240"
              "etiqueta" => "48"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Anti-hemojuvelin antibody corrects anemia caused by inappropriately high hepcidin levels"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "S&#46; Kovac"
                            1 => "P&#46; B&#246;ser"
                            2 => "Y&#46; Cui"
                            3 => "D&#46; Ferring-Appel"
                            4 => "D&#46; Casarrubea"
                            5 => "L&#46; Huang"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.3324/haematol.2015.140772"
                      "Revista" => array:6 [
                        "tituloSerie" => "Haematologica"
                        "fecha" => "2016"
                        "volumen" => "101"
                        "paginaInicial" => "e173"
                        "paginaFinal" => "e176"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26944476"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            48 => array:3 [
              "identificador" => "bib0245"
              "etiqueta" => "49"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Anti-repulsive guidance molecule C &#40;RGMc&#41; antibodies increases serum iron in rats and cynomolgus monkeys by hepcidin downregulation"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "P&#46; B&#246;ser"
                            1 => "D&#46; Seemann"
                            2 => "M&#46;J&#46; Liguori"
                            3 => "L&#46; Fan"
                            4 => "L&#46; Huang"
                            5 => "M&#46; Hafner"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1208/s12248-015-9770-4"
                      "Revista" => array:6 [
                        "tituloSerie" => "AAPS J"
                        "fecha" => "2015"
                        "volumen" => "17"
                        "paginaInicial" => "930"
                        "paginaFinal" => "938"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25896304"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            49 => array:3 [
              "identificador" => "bib0250"
              "etiqueta" => "50"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Targeting the hepcidin&#8211;ferroportin pathway in anaemia of chronic kidney disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Sheetz"
                            1 => "P&#46; Barrington"
                            2 => "S&#46; Callies"
                            3 => "P&#46;H&#46; Berg"
                            4 => "J&#46; McColm"
                            5 => "T&#46; Marbury"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/bcp.13877"
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Clin Pharmacol"
                        "fecha" => "2019"
                        "volumen" => "85"
                        "paginaInicial" => "935"
                        "paginaFinal" => "948"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30677788"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            50 => array:3 [
              "identificador" => "bib0255"
              "etiqueta" => "51"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46;U&#46; Steinbicker"
                            1 => "C&#46; Sachidanandan"
                            2 => "A&#46;J&#46; Vonner"
                            3 => "R&#46;Z&#46; Yusuf"
                            4 => "D&#46;Y&#46; Deng"
                            5 => "C&#46;S&#46; Lai"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1182/blood-2010-10-313064"
                      "Revista" => array:6 [
                        "tituloSerie" => "Blood"
                        "fecha" => "2011"
                        "volumen" => "117"
                        "paginaInicial" => "4915"
                        "paginaFinal" => "4923"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21393479"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            51 => array:3 [
              "identificador" => "bib0260"
              "etiqueta" => "52"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "I&#46; Theurl"
                            1 => "A&#46; Schroll"
                            2 => "T&#46; Sonnweber"
                            3 => "M&#46; Nairz"
                            4 => "M&#46; Theurl"
                            5 => "W&#46; Willenbacher"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1182/blood-2011-03-345066"
                      "Revista" => array:6 [
                        "tituloSerie" => "Blood"
                        "fecha" => "2011"
                        "volumen" => "118"
                        "paginaInicial" => "4977"
                        "paginaFinal" => "4984"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21730356"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            52 => array:3 [
              "identificador" => "bib0265"
              "etiqueta" => "53"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Hepcidin antagonists for potential treatments of disorders with hepcidin excess"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "M&#46; Poli"
                            1 => "M&#46; Asperti"
                            2 => "P&#46; Ruzzenenti"
                            3 => "M&#46; Regoni"
                            4 => "P&#46; Arosio"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.3389/fphar.2014.00086"
                      "Revista" => array:5 [
                        "tituloSerie" => "Front Pharmacol"
                        "fecha" => "2014"
                        "volumen" => "5"
                        "paginaInicial" => "86"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24808863"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            53 => array:3 [
              "identificador" => "bib0270"
              "etiqueta" => "54"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Non-anticoagulant heparins are hepcidin antagonists for the treatment of anemia"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "M&#46; Poli"
                            1 => "M&#46; Asperti"
                            2 => "P&#46; Ruzzenenti"
                            3 => "A&#46; Naggi"
                            4 => "P&#46; Arosio"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "tituloSerie" => "Molecules"
                        "fecha" => "2017"
                        "volumen" => "22"
                        "paginaInicial" => "598"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            54 => array:3 [
              "identificador" => "bib0275"
              "etiqueta" => "55"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A fully human anti-hepcidin antibody modulates iron metabolism in both mice and nonhuman primates"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "K&#46;S&#46; Cooke"
                            1 => "B&#46; Hinkle"
                            2 => "H&#46; Salimi-Moosavi"
                            3 => "I&#46; Foltz"
                            4 => "C&#46; King"
                            5 => "P&#46; Rathanaswami"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1182/blood-2013-06-505792"
                      "Revista" => array:6 [
                        "tituloSerie" => "Blood"
                        "fecha" => "2013"
                        "volumen" => "122"
                        "paginaInicial" => "3054"
                        "paginaFinal" => "3061"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23945155"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            55 => array:3 [
              "identificador" => "bib0280"
              "etiqueta" => "56"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A first-in-human phase 1 study of a hepcidin monoclonal antibody&#44; LY2787106&#44; in cancer-associated anemia"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "S&#46; Vadhan-Raj"
                            1 => "R&#46; Abonour"
                            2 => "J&#46;W&#46; Goldman"
                            3 => "D&#46;A&#46; Smith"
                            4 => "C&#46;A&#46; Slapak"
                            5 => "R&#46;L&#46; Ilaria Jr"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1186/s13045-017-0427-x"
                      "Revista" => array:5 [
                        "tituloSerie" => "J Hematol Oncol"
                        "fecha" => "2017"
                        "volumen" => "10"
                        "paginaInicial" => "73"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28327200"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            56 => array:3 [
              "identificador" => "bib0285"
              "etiqueta" => "57"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Anticalin proteins as therapeutic agents in human diseases"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "C&#46; Rothe"
                            1 => "A&#46; Skerra"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s40259-018-0278-1"
                      "Revista" => array:6 [
                        "tituloSerie" => "BioDrugs"
                        "fecha" => "2018"
                        "volumen" => "32"
                        "paginaInicial" => "233"
                        "paginaFinal" => "243"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29748739"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            57 => array:3 [
              "identificador" => "bib0290"
              "etiqueta" => "58"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "First-in-human Phase I studies of PRS-080&#35;22&#44; a hepcidin antagonist&#44; in healthy volunteers and patients with chronic kidney disease undergoing hemodialysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "L&#46; Renders"
                            1 => "K&#46; Budde"
                            2 => "C&#46; Rosenberger"
                            3 => "R&#46; van Swelm"
                            4 => "D&#46; Swinkels"
                            5 => "F&#46; Dellanna"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1371/journal.pone.0227202"
                      "Revista" => array:4 [
                        "tituloSerie" => "PLoS One"
                        "fecha" => "2019"
                        "volumen" => "14"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31891643"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            58 => array:3 [
              "identificador" => "bib0295"
              "etiqueta" => "59"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Safety&#44; pharmacokinetics and pharmacodynamics of the anti-hepcidin Spiegelmer lexaptepid pegol in healthy subjects"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Boyce"
                            1 => "S&#46; Warrington"
                            2 => "B&#46; Cortezi"
                            3 => "S&#46; Z&#246;llner"
                            4 => "S&#46; Vaul&#233;on"
                            5 => "D&#46;W&#46; Swinkels"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/bph.13433"
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Pharmacol"
                        "fecha" => "2016"
                        "volumen" => "173"
                        "paginaInicial" => "1580"
                        "paginaFinal" => "1588"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26773325"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            59 => array:3 [
              "identificador" => "bib0300"
              "etiqueta" => "60"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "High-throughput screening of small molecules identifies hepcidin antagonists"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "E&#46; Fung"
                            1 => "P&#46; Sugianto"
                            2 => "J&#46; Hsu"
                            3 => "R&#46; Damoiseaux"
                            4 => "T&#46; Ganz"
                            5 => "E&#46; Nemeth"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1124/mol.112.083428"
                      "Revista" => array:6 [
                        "tituloSerie" => "Mol Pharmacol"
                        "fecha" => "2013"
                        "volumen" => "83"
                        "paginaInicial" => "681"
                        "paginaFinal" => "690"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23292796"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/23870206/0000015600000005/v1_202103120836/S2387020621000528/v1_202103120836/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "44147"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Review"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/23870206/0000015600000005/v1_202103120836/S2387020621000528/v1_202103120836/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020621000528?idApp=UINPBA00004N"
]
Article information
ISSN: 23870206
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2023 March 4 4 8

Follow this link to access the full text of the article

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos